{"gene":"DTNBP1","run_date":"2026-06-09T23:54:42","timeline":{"discoveries":[{"year":2001,"finding":"Dysbindin (DTNBP1) is a novel coiled-coil-containing protein that binds directly to alpha- and beta-dystrobrevin in muscle and brain, is co-immunoprecipitated with dystrophin and alpha-dystrobrevin (indicating DPC association in muscle), co-localizes with alpha-dystrobrevin at the sarcolemma, and is found in axon bundles and mossy fiber synaptic terminals in brain.","method":"Yeast two-hybrid screen, co-immunoprecipitation, immunolocalization","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Strong — yeast two-hybrid plus reciprocal co-IP, replicated in multiple tissues; foundational identification paper","pmids":["11316798"],"is_preprint":false},{"year":2003,"finding":"Dysbindin binds to myospryn, a novel 413-kDa muscle protein, and the two proteins co-immunoprecipitate from muscle extracts and are extensively co-localized, demonstrating a tissue-specific binding partner for dysbindin in muscle.","method":"Yeast two-hybrid screen, co-immunoprecipitation, co-localization immunofluorescence","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — yeast two-hybrid plus co-IP in native tissue, single lab","pmids":["14688250"],"is_preprint":false},{"year":2004,"finding":"Overexpression of dysbindin in primary cortical neurons increases expression of presynaptic proteins SNAP25 and synapsin I and enhances extracellular glutamate release; siRNA knockdown reduces both presynaptic protein expression and glutamate release, indicating dysbindin regulates exocytotic glutamate release via upregulation of presynaptic machinery.","method":"Neuronal overexpression and siRNA knockdown, ELISA glutamate measurement, Western blotting","journal":"Human molecular genetics","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — complementary gain- and loss-of-function in primary neurons, single lab","pmids":["15345706"],"is_preprint":false},{"year":2004,"finding":"Dysbindin overexpression increases Akt phosphorylation and protects cortical neurons against serum deprivation-induced death via PI3-kinase–Akt signaling; these effects are blocked by the PI3-kinase inhibitor LY294002, and siRNA knockdown of dysbindin diminishes Akt phosphorylation and facilitates neuronal death.","method":"Neuronal overexpression and siRNA knockdown, pharmacological inhibition (LY294002), Western blotting for pAkt, cell viability assays","journal":"Human molecular genetics","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — bidirectional manipulation plus pharmacological epistasis, single lab","pmids":["15345706"],"is_preprint":false},{"year":2006,"finding":"Dysbindin-1 binds snapin in vitro and in brain; both proteins are concentrated in synaptic vesicle membrane fractions and less so in postsynaptic densities, with immunoelectron microscopy showing dysbindin-1 in synaptic vesicles of axospinous terminals and in postsynaptic densities and microtubules of hippocampal neurons.","method":"In vitro binding assay, tissue fractionation, co-immunoprecipitation, immunoelectron microscopy","journal":"Human molecular genetics","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — in vitro binding plus native co-IP plus ultrastructural localization, multiple orthogonal methods","pmids":["16980328"],"is_preprint":false},{"year":2006,"finding":"Dysbindin is a stable subunit of the BLOC-1 complex; within BLOC-1 its dystrobrevin-binding region (69-residue coiled-coil) is occupied by interactions with pallidin, snapin, and muted subunits. Recombinant dystrobrevin coiled-coil fragments fail to pull down endogenous BLOC-1 from brain or muscle, and immunoprecipitation of endogenous dysbindin from brain or muscle co-precipitates pallidin but not dystrobrevin isoforms, indicating that BLOC-1-assembled dysbindin is not a physiological dystrobrevin-binding partner.","method":"Yeast two-hybrid, recombinant protein binding assays, co-immunoprecipitation of endogenous proteins from brain and muscle","journal":"The Biochemical journal","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — reconstitution-level binding assays plus endogenous co-IP in multiple tissues, multiple orthogonal methods in one study","pmids":["16448387"],"is_preprint":false},{"year":2007,"finding":"DTNBP1 siRNA knockdown decreases dysbindin protein, increases cell-surface D2 receptor (DRD2) levels, and blocks dopamine-induced DRD2 internalization in SH-SY5Y cells and rat primary cortical neurons; MUTED siRNA produces similar effects; DRD1 levels and internalization are unaffected. Enhanced DRD2 surface levels lead to increased quinpirole-induced reduction of CREB phosphorylation, demonstrating augmented intracellular signaling.","method":"siRNA knockdown, flow cytometry / immunofluorescence for surface receptor quantification, Western blotting for pCREB","journal":"The Journal of neuroscience","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple cell types, reciprocal siRNA (DTNBP1 and MUTED), functional readout of downstream signaling, replicated in two cell systems","pmids":["17989303"],"is_preprint":false},{"year":2008,"finding":"Loss of dysbindin in sandy (sdy) mice causes larger dense-core vesicle size, slower quantal release kinetics, lower release probability, and a smaller readily releasable vesicle pool in neuroendocrine cells and hippocampal synapses, indicating dysbindin regulates exocytosis and vesicle biogenesis.","method":"Amperometry, whole-cell patch clamp, electron microscopy in dysbindin-null (sdy) mice","journal":"The Journal of cell biology","confidence":"High","confidence_rationale":"Tier 1 / Strong — three orthogonal biophysical methods in a genetic null model, single rigorous study","pmids":["18504299"],"is_preprint":false},{"year":2008,"finding":"Dysbindin-null (sdy) mice have reduced dopamine (but not glutamate) levels in cerebral cortex, hippocampus, and hypothalamus, linking dysbindin deficiency to reduced forebrain dopaminergic transmission.","method":"Neurochemical quantification (HPLC) in dysbindin-null (sdy) mice brain regions","journal":"Biochemical and biophysical research communications","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct neurochemical measurement in genetic null, single lab, single method","pmids":["18555792"],"is_preprint":false},{"year":2008,"finding":"In dysbindin-null (sdy) mice, steady-state snapin protein is reduced in hippocampus; a 30-residue peptide (amino acids 90–119) of dysbindin mediates the interaction with snapin, and its loss destabilizes snapin leading to abnormal neurotransmission.","method":"Western blotting in sdy mice, peptide binding/interaction mapping","journal":"Schizophrenia research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — domain mapping plus in vivo consequence in null mice, single lab","pmids":["18774265"],"is_preprint":false},{"year":2009,"finding":"TRIM32 is an E3 ubiquitin ligase that binds dysbindin via yeast two-hybrid, ubiquitinates it to augment its degradation, and siRNA knockdown of TRIM32 elevates dysbindin levels. LGMD2H/STM-associated mutations D487N and R394H impair ubiquitin ligase activity toward dysbindin while retaining dysbindin-binding ability; D487N can bind dysbindin and its E2 but is defective in monoubiquitination.","method":"Yeast two-hybrid, in vitro/cell-based ubiquitination assays, siRNA knockdown, Western blotting, co-immunoprecipitation","journal":"Human molecular genetics","confidence":"High","confidence_rationale":"Tier 1 / Strong — multiple orthogonal biochemical methods including direct ubiquitination assay plus mutagenesis of disease alleles, single rigorous study","pmids":["19349376"],"is_preprint":false},{"year":2009,"finding":"Drosophila dysbindin is required presynaptically for retrograde homeostatic modulation of neurotransmission in a dose-dependent manner, functioning downstream of or independently of calcium influx, as established by an electrophysiology-based forward genetic screen at the neuromuscular junction.","method":"Forward genetic screen, electrophysiology (mEJP, EJP recording), genetic epistasis with calcium channel mutations","journal":"Science","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — unbiased forward screen followed by electrophysiological and epistasis analysis in Drosophila ortholog","pmids":["19965435"],"is_preprint":false},{"year":2009,"finding":"In dysbindin-knockout (dys−/−) mice, D2 receptor (but not D1) surface expression is robustly increased due to enhanced recycling and insertion rather than reduced endocytosis; fast-spiking GABAergic interneurons in PFC and striatum show decreased excitability; inhibitory input to PFC pyramidal neurons is decreased; and D2 agonist produces a more pronounced increase in interneuron firing in dys−/− compared to wild-type.","method":"Cell imaging, biochemical fractionation, whole-cell electrophysiology, receptor trafficking assays in genetic knockout mice","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal methods (imaging, biochemistry, electrophysiology) in a genetic null model across multiple cell types","pmids":["19887632"],"is_preprint":false},{"year":2009,"finding":"Dysbindin controls hippocampal LTP by selectively reducing surface expression of NR2A (but not NR2B) NMDA receptor subunits; dysbindin-null hippocampal neurons show increased surface NR2A by imaging and biotinylation, increased NR2A-mediated synaptic currents, and enhanced LTP without changes in basal transmission, AMPA receptor currents, or LTD.","method":"Fluorescence imaging, surface biotinylation, whole-cell electrophysiology (patch clamp), LTP/LTD field recordings in hippocampal slices from genetic null mice","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — multiple orthogonal methods (imaging, biochemistry, electrophysiology, plasticity assays) in genetic null, single rigorous study","pmids":["19955431"],"is_preprint":false},{"year":2009,"finding":"Dysbindin-null mice show reduced paired-pulse facilitation and reduced evoked and miniature excitatory post-synaptic currents in deep-layer PFC pyramidal neurons, indicating a presynaptic deficit in glutamatergic transmission that is associated with impaired spatial working memory.","method":"Whole-cell patch clamp recordings in PFC slices, behavioral spatial working memory task in genetic null mice","journal":"Neuropsychopharmacology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — electrophysiology plus behavior in genetic null, single lab","pmids":["19641486"],"is_preprint":false},{"year":2009,"finding":"Direct interaction between dysbindin and the AP-3 complex is mediated through the mu subunit of AP-3; dysbindin partially co-localizes with AP-3 in hippocampal CA1/CA3 and at presynaptic terminals and growth cones; dysbindin suppression reduces presynaptic protein expression and glutamate release.","method":"Co-immunoprecipitation, in vitro binding assay, immunofluorescence co-localization, siRNA knockdown with glutamate release assay","journal":"Neurochemistry international","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct binding demonstrated in vitro plus native co-IP plus functional siRNA, single lab","pmids":["19428785"],"is_preprint":false},{"year":2009,"finding":"Proteomics of dysbindin-interacting proteins from rat brain identifies Munc18-1 as a binding partner; Munc18-1 co-immunoprecipitates with dysbindin from rat brain lysate, interacts directly in vitro, and co-localizes with dysbindin at presynaptic terminals in cultured hippocampal neurons.","method":"Affinity chromatography, MALDI-TOF/LC-MS/MS proteomics, co-immunoprecipitation, in vitro binding assay, immunofluorescence","journal":"Journal of neurochemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — mass spectrometry identification confirmed by co-IP and in vitro binding, single lab","pmids":["19573021"],"is_preprint":false},{"year":2009,"finding":"Cytosolic immunoprecipitation/mass spectrometry of dysbindin identifies novel interactions with members of the exocyst, dynactin, and chaperonin containing T-complex protein (CCT) complexes, in addition to confirming all BLOC-1 and AP-3 subunit interactions.","method":"Co-immunoprecipitation, mass spectrometry, Western blot validation in mammalian cells","journal":"Journal of neurochemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — MS-based interactome with validation by Western blot, single lab","pmids":["20236384"],"is_preprint":false},{"year":2010,"finding":"Dysbindin knockdown in HEK293 and HeLa cells specifically reduces post-endocytic lysosomal trafficking of internalized D2 receptors (and delta opioid receptors) without affecting receptor endocytosis; dysbindin co-immunoprecipitates with GASP-1 and HRS (ESCRT component), suggesting it promotes lysosomal sorting of specific GPCRs.","method":"RNA interference, immunochemistry, biochemical trafficking assays, co-immunoprecipitation in non-neuronal cells","journal":"PloS one","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple receptor substrates tested, co-IP of interaction partners, single lab","pmids":["20174469"],"is_preprint":false},{"year":2010,"finding":"Dysbindin-1 and WAVE2 and Abi-1 form a ternary complex; dysbindin-1 promotes the binding of WAVE2 to Abi-1; siRNA knockdown of dysbindin-1 in hippocampal neurons leads to elongated immature dendritic protrusions, indicating a role in dendritic spine morphogenesis.","method":"Co-immunoprecipitation, yeast two-hybrid, RNAi knockdown with morphological analysis of dendritic spines","journal":"Molecular psychiatry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — complex formation demonstrated by co-IP plus loss-of-function morphological phenotype, single lab","pmids":["20531346"],"is_preprint":false},{"year":2010,"finding":"Dysbindin-1 is a nucleocytoplasmic shuttling protein with a functional nuclear export signal; inhibition of CRM1/exportin-1-mediated nuclear export (leptomycin B) causes nuclear accumulation of dysbindin-1; nucleocytoplasmic shuttling regulates synapsin I expression; dysbindin-1-null (sdy) mice have reduced synapsin I protein and mRNA.","method":"Leptomycin B treatment, nuclear export signal mutagenesis, subcellular fractionation, Western blotting in sandy mice","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — pharmacological nuclear export block plus mutagenesis plus in vivo null mouse confirmation, single lab","pmids":["20921223"],"is_preprint":false},{"year":2010,"finding":"Dysbindin deficiency in dys−/− mice is associated with reduced NMDA-evoked currents in PFC pyramidal neurons and decreased NR1 subunit expression; the degree of NR1 expression correlates with spatial working memory performance.","method":"Whole-cell recordings in PFC slices, quantitative RT-PCR for NR1, behavioral spatial working memory testing in genetic null mice","journal":"Biological psychiatry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — electrophysiology plus molecular quantification plus behavior in genetic null, single lab","pmids":["21035792"],"is_preprint":false},{"year":2010,"finding":"Dysbindin-1 disruption in dys−/− mice reduces CaMKII and CaMKKβ expression in mPFC; chronic D2 agonist treatment reproduces these protein expression changes; dys−/− pyramidal neurons are hyperexcitable at baseline but hypoexcitable following D2 stimulation.","method":"Western blotting, in vivo electrophysiology, pharmacological D2 manipulation in genetic knockout mice","journal":"Molecular psychiatry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple biochemical and electrophysiological methods in genetic null with pharmacological epistasis, single lab","pmids":["20956979"],"is_preprint":false},{"year":2011,"finding":"DISC1 aggresomes recruit dysbindin via a direct interaction mapped to DISC1 residues 316–597 and dysbindin residues 82–173; direct interaction between soluble DISC1 and dysbindin is demonstrated in a cell-free system using E. coli-expressed proteins; co-aggregation of both proteins is found in postmortem brains of mental disease patients but not healthy controls.","method":"Cell transfection aggresome assay, E. coli recombinant protein binding assay, postmortem brain biochemical fractionation and co-immunoprecipitation","journal":"Biological psychiatry","confidence":"Medium","confidence_rationale":"Tier 1–2 / Moderate — cell-free direct binding plus domain mapping plus postmortem brain confirmation, single lab","pmids":["21531389"],"is_preprint":false},{"year":2011,"finding":"Dysbindin assembles into BLOC-1, which interacts with AP-3; BLOC-1/AP-3 deficiencies reduce PI4KIIα content in the dentate gyrus of dysbindin-null mice due to a failure to traffic PI4KIIα from cell bodies to neurites, defining a BLOC-1/AP-3-dependent vesicle transport mechanism for cargo sorting from neuronal cell bodies to nerve terminals.","method":"Co-purification, AP-3 and BLOC-1 knockout mouse analysis, immunofluorescence in primary neurons and PC12 cells, AP-3 sorting motif mutagenesis","journal":"Molecular biology of the cell","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple genetic models (dysbindin null, AP-3 null), biochemical co-purification, mutagenesis of sorting motif, multiple orthogonal approaches","pmids":["21998198"],"is_preprint":false},{"year":2011,"finding":"Dysbindin-1 isoforms show distinct subsynaptic localizations: dysbindin-1B is predominantly associated with synaptic vesicles, while dysbindin-1A and -1C are predominantly in postsynaptic densities, as determined by Western blotting of subsynaptic tissue fractions.","method":"Subcellular fractionation, Western blotting of subsynaptic fractions from multiple brain areas","journal":"PloS one","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — systematic fractionation of multiple brain regions, single lab","pmids":["21390302"],"is_preprint":false},{"year":2011,"finding":"Dysbindin-1 recruits necdin to the cytoplasm, attenuating necdin's repression of p53 transcriptional activity; dysbindin-1 knockdown reduces p53 target genes coronin 1b and rab13, impairing neurite outgrowth; overexpression of p53 rescues neurite outgrowth blocked by dysbindin-1 knockdown; sandy mouse neurons show reduced p21, coronin 1b, and rab13 and neurite outgrowth defects.","method":"Yeast two-hybrid, co-immunoprecipitation, siRNA knockdown, p53 reporter assay, neurite outgrowth imaging in primary neurons from sdy mice","journal":"Molecular psychiatry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple complementary methods including reporter assay, rescue experiment, and in vivo null mouse validation, single lab","pmids":["21502952"],"is_preprint":false},{"year":2011,"finding":"Drosophila dysbindin (Ddysb) reduced in presynaptic neurons suppresses glutamatergic synaptic transmission causing memory impairment; reduced Ddysb in glial cells causes hyperdopaminergic activity by altering expression of the dopamine metabolic enzyme Ebony, leading to abnormal locomotion.","method":"Cell-type-specific RNAi (neuronal vs. glial), electrophysiology, behavioral assays, Ebony expression analysis in Drosophila","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 / Strong — cell-type-specific genetic dissection with electrophysiology and behavioral and molecular readouts, mechanistically rigorous","pmids":["22049342"],"is_preprint":false},{"year":2013,"finding":"Dysbindin binds RhoA and activates RhoA-SRF and MEK1-ERK1 signaling pathways in cardiomyocytes, inducing cardiac hypertrophy; RhoA was identified as a novel dysbindin-binding partner by yeast two-hybrid and confirmed by co-immunoprecipitation.","method":"Yeast two-hybrid, co-immunoprecipitation, SRF luciferase reporter assay, Western blotting, morphological hypertrophy measurements in neonatal rat cardiomyocytes","journal":"The Journal of cell biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — yeast two-hybrid plus co-IP plus functional reporter, single lab","pmids":["24385487"],"is_preprint":false},{"year":2013,"finding":"Dysbindin-1 null (sdy) mice show reduced NMDAR-dependent LTP in hippocampal CA1 that is rescued by exogenous glycine (NMDAR co-agonist), indicating impaired NMDAR function underlies the plasticity deficit; homozygous null mice also show deficits in contextual fear conditioning.","method":"Hippocampal slice field recordings (LTP), pharmacological rescue with glycine, contextual fear conditioning in genetic null mice","journal":"Hippocampus","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — electrophysiology with pharmacological rescue plus behavioral phenotype in genetic null, single lab","pmids":["24446171"],"is_preprint":false},{"year":2013,"finding":"Dysbindin-1 null mice have a decreased readily releasable pool of synaptic vesicles, decreased quantal size, decreased release probability, deficits in endo- and exocytosis rates, decreased intracellular Ca2+, reduced expression of L- and N-type Ca2+ channels, and reduced expression of synaptic vesicle trafficking and priming proteins in PFC.","method":"Electrophysiology, vesicle imaging, calcium imaging, Western blotting in dysbindin-null mice","journal":"Schizophrenia research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple physiological and biochemical methods in genetic null, single lab","pmids":["23473812"],"is_preprint":false},{"year":2014,"finding":"Dysbindin-1C isoform (but not -1A) is specifically localized to hilar glutamatergic mossy cells in dentate gyrus; loss of dysbindin-1C (in sdy mice) reduces mossy cell numbers and causes delayed maturation of adult-born neurons, whereas muted mice (in which dysbindin-1A is destabilized but -1C is intact) do not show this phenotype.","method":"Immunohistochemistry for isoform-specific localization, comparison of sdy and muted mouse hippocampal phenotypes, BrdU/doublecortin labeling for neurogenesis","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — isoform-specific localization plus comparative genetic mouse models, single lab","pmids":["25157109"],"is_preprint":false},{"year":2014,"finding":"Dysbindin-null neurons show hyperactive dendritic protrusion dynamics (increased formation, retraction, and conversion); CaMKIIα is required for mushroom/thin spine stabilization; the hyperactivity in dysbindin-null neurons is attributed in part to decreased CaMKIIα activity resulting from increased Abi1-mediated inhibition of CaMKIIα.","method":"Time-lapse live imaging of hippocampal neurons from dysbindin-null mice, CaMKIIα activity assays, Abi1 co-immunoprecipitation","journal":"The Journal of neuroscience","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — live-cell imaging plus mechanistic epistasis analysis, single lab","pmids":["25297099"],"is_preprint":false},{"year":2015,"finding":"Dysbindin-1 deficiency reduces BDNF exocytosis from cortical excitatory neurons (measured by TIRF microscopy); this reduction in BDNF release transsynaptically decreases the number of inhibitory synapses on excitatory neurons; exogenous BDNF rescues the inhibitory synaptic deficits caused by reduced dysbindin-1 in cultured neurons and slice cultures.","method":"TIRF microscopy (live-cell BDNF exocytosis imaging), whole-cell recordings, immunohistochemistry, exogenous BDNF rescue in cortical neurons and organotypic slices","journal":"Biological psychiatry","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal methods (TIRF, electrophysiology, IHC, rescue experiment) establishing a mechanistic pathway, single rigorous study","pmids":["26386481"],"is_preprint":false},{"year":2015,"finding":"Dysbindin/BLOC-1 deficiency reduces expression of Arp2/3 complex subunits in neuronal cells, impairs actin dynamics in early endosomes, and Arp2/3, dysbindin, and BLOC-1 subunits biochemically and genetically interact in Drosophila to modulate synapse morphology and homeostatic plasticity.","method":"Quantitative mass spectrometry proteomics, Western blot validation, actin dynamics assay, co-immunoprecipitation, Drosophila genetic interaction (synapse morphology and electrophysiology)","journal":"The Journal of neuroscience","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — unbiased proteomics confirmed by multiple methods plus genetic epistasis in Drosophila with electrophysiological phenotype","pmids":["27927957"],"is_preprint":false},{"year":2015,"finding":"Dysbindin/BLOC-1 genetically and biochemically interacts with the copper transporter ATP7A; BLOC-1-null mice show altered transcriptional profiles of copper-regulatory and dependent factors in hippocampus; dysbindin/BLOC-1 loss-of-function alleles increase susceptibility to toxic copper challenges in mammalian cells and Drosophila without changing basal copper content.","method":"Co-immunoprecipitation, transcriptomic analysis in BLOC-1-null mice, copper toxicity assays in cells and Drosophila, genetic interaction analysis","journal":"Human molecular genetics","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — biochemical interaction plus multiple genetic models plus functional toxicity assays, single lab","pmids":["26199316"],"is_preprint":false},{"year":2015,"finding":"N-ethylmaleimide-sensitive factor (NSF) protein levels are downregulated in dysbindin/BLOC-1-deficient cells; human dysbindin/BLOC-1 co-precipitates with NSF; in Drosophila, presynaptic expression of either dysbindin or NSF fully rescues the dysbindin-mutant failure of homeostatic synaptic plasticity.","method":"Proteome-wide screen, co-immunoprecipitation, Drosophila genetic rescue of homeostatic plasticity (electrophysiology)","journal":"The Journal of neuroscience","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — proteomics identification confirmed by co-IP plus genetic rescue in Drosophila electrophysiology, single lab","pmids":["25972187"],"is_preprint":false},{"year":2017,"finding":"TRIM24 binds dysbindin (identified by yeast two-hybrid, confirmed by co-IP) and protects dysbindin from TRIM32-mediated degradation in cardiomyocytes; TRIM32 degrades dysbindin in cardiomyocytes (as in skeletal muscle), attenuating dysbindin-driven SRF signaling and hypertrophy; TRIM24 overexpression promotes dysbindin-dependent SRF activation and hypertrophy.","method":"Yeast two-hybrid, co-immunoprecipitation, co-immunostaining, Western blotting for dysbindin levels after TRIM24/TRIM32 manipulation, SRF luciferase reporter assay, cardiomyocyte hypertrophy measurements","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — yeast two-hybrid plus co-IP plus functional reporter assays, single lab","pmids":["28465353"],"is_preprint":false},{"year":2018,"finding":"Dysbindin regulates access to EGTA-sensitive (loosely coupled) synaptic vesicles; presynaptic proteasome inhibition potentiates release under baseline conditions but not during homeostatic plasticity, and this effect requires dysbindin; genetic evidence indicates dysbindin levels control the pool of low-release-probability vesicles recruited during homeostatic plasticity at the Drosophila NMJ.","method":"Drosophila NMJ electrophysiology, pharmacological proteasome inhibition, EGTA sensitivity assays, genetic epistasis with dysbindin mutants","journal":"Nature communications","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — electrophysiology plus pharmacology plus genetic epistasis in Drosophila, single lab","pmids":["29348419"],"is_preprint":false},{"year":2018,"finding":"Genetic variants reducing dysbindin-1 expression alter cognitive response to antipsychotics through an imbalance between short and long isoforms of dopamine D2 receptors, leading to enhanced presynaptic D2 function within the prefrontal cortex; this was demonstrated in postmortem human brains and genetically modified mice.","method":"Postmortem human brain analysis, genetically modified mice, D2 receptor isoform quantification, behavioral pharmacology","journal":"Nature communications","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — convergent human postmortem and mouse genetic data with molecular mechanism, single lab","pmids":["29891954"],"is_preprint":false},{"year":2008,"finding":"siRNA knockdown of dysbindin in SH-SY5Y cells causes aberrant actin cytoskeleton organization; growth cones of hippocampal neurons from sandy mice show similar morphological abnormalities; dysbindin expression level correlates with JNK phosphorylation, suggesting dysbindin regulates JNK signaling and actin cytoskeleton organization.","method":"siRNA knockdown, phalloidin/immunofluorescence for actin morphology, Western blotting for pJNK in cell lines and primary neurons from sdy mice","journal":"Biochemical and biophysical research communications","confidence":"Low","confidence_rationale":"Tier 3 / Weak — correlation between dysbindin levels and pJNK without direct mechanistic intervention; single lab, single method per readout","pmids":["19094965"],"is_preprint":false}],"current_model":"Dysbindin-1 (DTNBP1) is a coiled-coil protein that assembles as a core subunit of the octameric BLOC-1 complex, which together with AP-3 mediates endosomal sorting of membrane cargoes (including D2 dopamine receptors and delta-opioid receptors) toward lysosomes and traffics proteins from neuronal cell bodies to nerve terminals; presynaptically, dysbindin regulates vesicle biogenesis, the size of the readily releasable pool, and exocytosis kinetics, thereby controlling glutamate and BDNF release; postsynaptically, it limits NR2A surface expression and modulates LTP; it also undergoes nucleocytoplasmic shuttling via a CRM1-dependent NES to regulate synapsin I expression, interacts with snapin, Munc18-1, WAVE2/Abi-1, RhoA, and DISC1 for diverse synaptic and cytoskeletal functions, and is ubiquitinated and degraded by the E3 ligase TRIM32 (antagonized by TRIM24)."},"narrative":{"mechanistic_narrative":"Dysbindin-1 (DTNBP1) is a coiled-coil protein that functions as a core, stably assembled subunit of the octameric BLOC-1 complex, coordinating endosomal cargo sorting and presynaptic vesicle biology in neurons [PMID:16448387, PMID:21998198]. Originally identified as a direct binding partner of alpha- and beta-dystrobrevin in muscle and brain [PMID:11316798], its dystrobrevin-binding coiled-coil region is in fact occupied within assembled BLOC-1 by pallidin, snapin, and muted, so the physiological pool is BLOC-1-bound rather than dystrobrevin-bound [PMID:16448387]. Acting with the AP-3 complex through the AP-3 mu subunit, BLOC-1/dysbindin traffics cargo such as PI4KIIalpha from neuronal cell bodies to nerve terminals [PMID:19428785, PMID:21998198], and directs internalized D2 dopamine and delta-opioid receptors toward lysosomal degradation via interactions with GASP-1 and HRS, so that dysbindin loss elevates surface D2 receptor and augments downstream signaling [PMID:17989303, PMID:20174469]. Presynaptically, dysbindin sets dense-core and synaptic vesicle size, the readily releasable pool, release probability, and exo/endocytosis kinetics, thereby controlling glutamate and BDNF release [PMID:18504299, PMID:23473812, PMID:26386481]; in Drosophila it is required for retrograde homeostatic modulation of release acting together with NSF and the Arp2/3 actin machinery [PMID:19965435, PMID:27927957, PMID:25972187]. Postsynaptically it limits surface NR2A NMDA receptor expression and constrains hippocampal LTP [PMID:19955431], and it shapes dendritic spine morphogenesis through a ternary complex with WAVE2 and Abi-1 [PMID:20531346, PMID:25297099]. Dysbindin also undergoes CRM1-dependent nucleocytoplasmic shuttling that regulates synapsin I expression [PMID:20921223] and is degraded by the E3 ubiquitin ligase TRIM32, an activity antagonized by TRIM24 [PMID:19349376, PMID:28465353].","teleology":[{"year":2001,"claim":"Established the molecular identity of dysbindin as a coiled-coil protein with a defined binding partner, anchoring it to the dystrophin/dystrobrevin protein complex in muscle and to synaptic terminals in brain.","evidence":"Yeast two-hybrid, reciprocal co-IP, and immunolocalization in muscle and brain","pmids":["11316798"],"confidence":"High","gaps":["Did not establish whether dystrobrevin binding occurs in the physiological assembled state","No functional role defined"]},{"year":2006,"claim":"Resolved the apparent dystrobrevin association by showing dysbindin is a stable BLOC-1 subunit whose coiled-coil region is occupied by pallidin, snapin, and muted, reframing its physiological context as an endosomal sorting complex.","evidence":"Yeast two-hybrid, recombinant binding assays, and endogenous co-IP from brain and muscle (plus snapin interaction and ultrastructural localization to synaptic vesicles)","pmids":["16448387","16980328"],"confidence":"High","gaps":["BLOC-1 cargo repertoire not yet defined","Functional consequence of snapin binding not yet established"]},{"year":2004,"claim":"First functional role in neurons: bidirectional manipulation showed dysbindin promotes presynaptic protein expression and glutamate release and supports neuronal survival via PI3K-Akt signaling.","evidence":"Overexpression/siRNA in primary cortical neurons with glutamate ELISA, pAkt Western, and LY294002 epistasis","pmids":["15345706"],"confidence":"Medium","gaps":["Mechanism linking dysbindin to Akt activation unresolved","Single lab, overexpression-based"]},{"year":2008,"claim":"Genetic-null analysis defined dysbindin as a regulator of vesicle biogenesis and exocytosis, controlling dense-core vesicle size, release probability, and the readily releasable pool.","evidence":"Amperometry, patch clamp, and EM in sandy (sdy) dysbindin-null mice","pmids":["18504299"],"confidence":"High","gaps":["Molecular link from BLOC-1 to vesicle biophysics not mapped","Did not distinguish dense-core from clear-vesicle pathways mechanistically"]},{"year":2009,"claim":"Connected dysbindin/BLOC-1 to GPCR trafficking and dopaminergic signaling, showing it limits surface D2 receptor levels and shapes interneuron and pyramidal excitability and working memory.","evidence":"siRNA and knockout-mouse imaging, fractionation, receptor trafficking assays, and electrophysiology (D2 surface levels, pCREB readouts)","pmids":["17989303","19887632","19641486"],"confidence":"High","gaps":["Whether D2 effect is via altered recycling vs degradation initially ambiguous","Selectivity for D2 over D1 mechanism not fully explained"]},{"year":2009,"claim":"Identified the postsynaptic NMDA receptor arm and presynaptic interactome, showing dysbindin selectively restrains surface NR2A to constrain LTP and binds Munc18-1 and AP-3 mu at terminals.","evidence":"Imaging/biotinylation and LTP recordings in null mice; proteomics, co-IP, and in vitro binding for Munc18-1 and AP-3","pmids":["19955431","19573021","19428785"],"confidence":"High","gaps":["Mechanism of NR2A-selective regulation undefined","How vesicle partners and trafficking integrate not resolved"]},{"year":2009,"claim":"Defined a degradation control point: TRIM32 ubiquitinates dysbindin to drive its turnover, with LGMD2H/STM disease alleles impairing this ligase activity.","evidence":"Yeast two-hybrid, in vitro/cell ubiquitination assays, siRNA, and disease-allele mutagenesis (D487N, R394H)","pmids":["19349376"],"confidence":"High","gaps":["Physiological signals controlling TRIM32-dysbindin turnover unknown","In vivo consequence of altered turnover not tested"]},{"year":2011,"claim":"Mechanistically unified dysbindin's trafficking role by showing BLOC-1/AP-3 transports cargo (PI4KIIalpha) from neuronal cell bodies to neurites, defining the somatodendritic-to-terminal sorting pathway.","evidence":"Co-purification, AP-3 and BLOC-1 knockout mice, sorting-motif mutagenesis, and imaging in neurons/PC12 cells","pmids":["21998198"],"confidence":"High","gaps":["Full cargo set transported by this route not enumerated","Link between cargo mis-sorting and synaptic phenotypes incompletely traced"]},{"year":2011,"claim":"Expanded dysbindin beyond trafficking into cytoskeletal, nuclear, and transcriptional roles, including WAVE2/Abi-1-dependent spine morphogenesis, CRM1-dependent shuttling regulating synapsin I, and necdin/p53-dependent neurite outgrowth.","evidence":"Co-IP/Y2H, RNAi morphology, leptomycin B/NES mutagenesis, and p53 reporter/rescue assays in neurons and sdy mice","pmids":["20531346","20921223","21502952"],"confidence":"Medium","gaps":["Relationship between nuclear shuttling and BLOC-1 function unclear","Single-lab findings for several non-canonical roles"]},{"year":2011,"claim":"Linked dysbindin to disease-relevant protein interactions and Drosophila cell-type dissection, including direct DISC1 binding/co-aggregation in patient brain and distinct neuronal vs glial roles controlling glutamatergic transmission and dopamine metabolism.","evidence":"Cell-free recombinant binding/domain mapping and postmortem brain co-IP; cell-type-specific RNAi with electrophysiology and behavior in Drosophila","pmids":["21531389","22049342"],"confidence":"Medium","gaps":["Functional consequence of DISC1 co-aggregation in vivo not established","Conservation of glial mechanism to mammals untested"]},{"year":2015,"claim":"Defined effector machinery for homeostatic plasticity and actin-dependent endosomal function, showing dysbindin/BLOC-1 controls NSF and Arp2/3 levels and copper-stress resistance, with NSF or dysbindin rescuing homeostatic plasticity in Drosophila.","evidence":"Proteome-wide screens, co-IP, actin dynamics assays, and Drosophila genetic rescue/interaction electrophysiology","pmids":["27927957","25972187","26199316"],"confidence":"High","gaps":["Direct vs indirect regulation of NSF/Arp2/3 abundance unresolved","Mammalian relevance of copper phenotype incompletely defined"]},{"year":2015,"claim":"Identified a transsynaptic signaling output: dysbindin controls BDNF exocytosis from excitatory neurons, which in turn sets the number of inhibitory synapses, rescuable by exogenous BDNF.","evidence":"TIRF live-cell BDNF imaging, whole-cell recordings, IHC, and BDNF rescue in cortical neurons and slices","pmids":["26386481"],"confidence":"High","gaps":["Mechanism coupling dysbindin to BDNF vesicle exocytosis specifically not detailed","In vivo circuit-level validation limited"]},{"year":2017,"claim":"Established antagonistic control of dysbindin stability beyond muscle, with TRIM24 shielding dysbindin from TRIM32-mediated degradation to tune RhoA-SRF-driven cardiomyocyte hypertrophy.","evidence":"Yeast two-hybrid, co-IP, TRIM24/TRIM32 manipulation Westerns, and SRF reporter/hypertrophy assays in cardiomyocytes","pmids":["28465353","24385487"],"confidence":"Medium","gaps":["Whether TRIM24/TRIM32 balance regulates neuronal dysbindin untested","Upstream regulation of the TRIM switch unknown"]},{"year":2018,"claim":"Refined the dopaminergic mechanism and clinical relevance, showing dysbindin expression controls vesicle pools recruited during homeostatic plasticity and the D2 short/long isoform balance shaping prefrontal D2 function and antipsychotic response.","evidence":"Drosophila NMJ electrophysiology with proteasome inhibition/EGTA assays; postmortem human brain and genetically modified mouse D2 isoform analysis","pmids":["29348419","29891954"],"confidence":"Medium","gaps":["Causal chain from dysbindin level to D2 isoform ratio not fully mapped","Single-lab human-mouse convergence"]},{"year":null,"claim":"How dysbindin's multiple roles—BLOC-1 endosomal sorting, presynaptic vesicle pool control, postsynaptic receptor surface regulation, nuclear shuttling, and proteostatic turnover—are coordinated within a single neuron and selectively engaged across cell types remains unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No integrated model linking BLOC-1 trafficking to the non-canonical nuclear/transcriptional roles","Structural basis of cargo selection by dysbindin/BLOC-1 undefined","In vivo hierarchy of pre- vs post-synaptic dysbindin functions unestablished"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0060090","term_label":"molecular adaptor activity","supporting_discovery_ids":[5,15,24]},{"term_id":"GO:0008092","term_label":"cytoskeletal protein binding","supporting_discovery_ids":[19,34,32]},{"term_id":"GO:0005198","term_label":"structural molecule activity","supporting_discovery_ids":[5]}],"localization":[{"term_id":"GO:0005768","term_label":"endosome","supporting_discovery_ids":[18,24,34]},{"term_id":"GO:0031410","term_label":"cytoplasmic vesicle","supporting_discovery_ids":[4,7,25]},{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[17,20]},{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[20]},{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[6,12,18]}],"pathway":[{"term_id":"R-HSA-5653656","term_label":"Vesicle-mediated transport","supporting_discovery_ids":[18,24,6]},{"term_id":"R-HSA-112316","term_label":"Neuronal System","supporting_discovery_ids":[7,13,30,33]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[6,12,28]},{"term_id":"R-HSA-392499","term_label":"Metabolism of proteins","supporting_discovery_ids":[10,37]},{"term_id":"R-HSA-9609507","term_label":"Protein localization","supporting_discovery_ids":[24]}],"complexes":["BLOC-1"],"partners":["SNAPIN","PLDN","MUTED","AP3M1","STXBP1","WASF2","ABI1","TRIM32"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"Q96EV8","full_name":"Dysbindin","aliases":["Biogenesis of lysosome-related organelles complex 1 subunit 8","BLOC-1 subunit 8","Dysbindin-1","Dystrobrevin-binding protein 1","Hermansky-Pudlak syndrome 7 protein","HPS7 protein"],"length_aa":351,"mass_kda":39.5,"function":"Component of the BLOC-1 complex, a complex that is required for normal biogenesis of lysosome-related organelles (LRO), such as platelet dense granules and melanosomes. In concert with the AP-3 complex, the BLOC-1 complex is required to target membrane protein cargos into vesicles assembled at cell bodies for delivery into neurites and nerve terminals. The BLOC-1 complex, in association with SNARE proteins, is also proposed to be involved in neurite extension. Associates with the BLOC-2 complex to facilitate the transport of TYRP1 independent of AP-3 function. Plays a role in synaptic vesicle trafficking and in neurotransmitter release. Plays a role in the regulation of cell surface exposure of DRD2. May play a role in actin cytoskeleton reorganization and neurite outgrowth. May modulate MAPK8 phosphorylation. Appears to promote neuronal transmission and viability through regulating the expression of SNAP25 and SYN1, modulating PI3-kinase-Akt signaling and influencing glutamatergic release. Regulates the expression of SYN1 through binding to its promoter. Modulates prefrontal cortical activity via the dopamine/D2 pathway","subcellular_location":"Cytoplasm; Cytoplasmic vesicle membrane; Cytoplasmic vesicle, secretory vesicle, synaptic vesicle membrane; Endosome membrane; Melanosome membrane; Postsynaptic cell membrane; Endoplasmic reticulum","url":"https://www.uniprot.org/uniprotkb/Q96EV8/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/DTNBP1","classification":"Not Classified","n_dependent_lines":4,"n_total_lines":1208,"dependency_fraction":0.0033112582781456954},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/DTNBP1","total_profiled":1310},"omim":[{"mim_id":"620388","title":"DYSBINDIN DOMAIN-CONTAINING PROTEIN 1; DBNDD1","url":"https://www.omim.org/entry/620388"},{"mim_id":"620098","title":"DEVELOPMENTAL DELAY WITH VARIABLE INTELLECTUAL DISABILITY AND DYSMORPHIC FACIES; DIDDF","url":"https://www.omim.org/entry/620098"},{"mim_id":"615178","title":"KXDL MOTIF-CONTAINING PROTEIN 1; KXD1","url":"https://www.omim.org/entry/615178"},{"mim_id":"614076","title":"HERMANSKY-PUDLAK SYNDROME 7; HPS7","url":"https://www.omim.org/entry/614076"},{"mim_id":"612193","title":"CARDIOMYOPATHY-ASSOCIATED PROTEIN 5; CMYA5","url":"https://www.omim.org/entry/612193"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Enhanced","locations":[{"location":"Microtubules","reliability":"Enhanced"},{"location":"Midbody","reliability":"Additional"}],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in all","driving_tissues":[{"tissue":"brain","ntpm":89.8},{"tissue":"retina","ntpm":117.7}],"url":"https://www.proteinatlas.org/search/DTNBP1"},"hgnc":{"alias_symbol":["Dysbindin","My031","HPS7","DBND","BLOC1S8"],"prev_symbol":[]},"alphafold":{"accession":"Q96EV8","domains":[],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q96EV8","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q96EV8-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q96EV8-F1-predicted_aligned_error_v6.png","plddt_mean":74.88},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=DTNBP1","jax_strain_url":"https://www.jax.org/strain/search?query=DTNBP1"},"sequence":{"accession":"Q96EV8","fasta_url":"https://rest.uniprot.org/uniprotkb/Q96EV8.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q96EV8/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q96EV8"}},"corpus_meta":[{"pmid":"12098102","id":"PMC_12098102","title":"Genetic variation in the 6p22.3 gene DTNBP1, the human ortholog of the mouse dysbindin gene, is associated with schizophrenia.","date":"2002","source":"American journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/12098102","citation_count":623,"is_preprint":false},{"pmid":"15345706","id":"PMC_15345706","title":"Evidence of novel neuronal functions of dysbindin, a susceptibility gene for schizophrenia.","date":"2004","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/15345706","citation_count":280,"is_preprint":false},{"pmid":"11316798","id":"PMC_11316798","title":"Dysbindin, a novel coiled-coil-containing protein that interacts with the dystrobrevins in muscle and brain.","date":"2001","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11316798","citation_count":254,"is_preprint":false},{"pmid":"19965435","id":"PMC_19965435","title":"The schizophrenia susceptibility gene dysbindin controls synaptic homeostasis.","date":"2009","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/19965435","citation_count":181,"is_preprint":false},{"pmid":"14618545","id":"PMC_14618545","title":"The DTNBP1 (dysbindin) gene contributes to schizophrenia, depending on family history of the disease.","date":"2003","source":"American journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/14618545","citation_count":160,"is_preprint":false},{"pmid":"15917270","id":"PMC_15917270","title":"Haplotypes at the dystrobrevin binding protein 1 (DTNBP1) gene locus mediate risk for schizophrenia through reduced DTNBP1 expression.","date":"2005","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/15917270","citation_count":150,"is_preprint":false},{"pmid":"15066891","id":"PMC_15066891","title":"Identification in 2 independent samples of a novel schizophrenia risk haplotype of the dystrobrevin binding protein gene (DTNBP1).","date":"2004","source":"Archives of general psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/15066891","citation_count":147,"is_preprint":false},{"pmid":"15362017","id":"PMC_15362017","title":"Association of the DTNBP1 locus with schizophrenia in a U.S. population.","date":"2004","source":"American journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/15362017","citation_count":134,"is_preprint":false},{"pmid":"16415041","id":"PMC_16415041","title":"Genetic variation in DTNBP1 influences general cognitive ability.","date":"2006","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/16415041","citation_count":134,"is_preprint":false},{"pmid":"18504299","id":"PMC_18504299","title":"DTNBP1, a schizophrenia susceptibility gene, affects kinetics of transmitter release.","date":"2008","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/18504299","citation_count":129,"is_preprint":false},{"pmid":"16980328","id":"PMC_16980328","title":"Dysbindin-1 is a synaptic and microtubular protein that binds brain snapin.","date":"2006","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/16980328","citation_count":128,"is_preprint":false},{"pmid":"19887632","id":"PMC_19887632","title":"Role of dysbindin in dopamine receptor trafficking and cortical GABA function.","date":"2009","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/19887632","citation_count":125,"is_preprint":false},{"pmid":"15121479","id":"PMC_15121479","title":"Strong evidence for association between the dystrobrevin binding protein 1 gene (DTNBP1) and schizophrenia in 488 parent-offspring trios from Bulgaria.","date":"2004","source":"Biological psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/15121479","citation_count":122,"is_preprint":false},{"pmid":"16199828","id":"PMC_16199828","title":"Relationship between a high-risk haplotype in the DTNBP1 (dysbindin) gene and clinical features of schizophrenia.","date":"2005","source":"The American journal of psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/16199828","citation_count":120,"is_preprint":false},{"pmid":"12808430","id":"PMC_12808430","title":"Identification of a high-risk haplotype for the dystrobrevin binding protein 1 (DTNBP1) gene in the Irish study of high-density schizophrenia families.","date":"2003","source":"Molecular psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/12808430","citation_count":118,"is_preprint":false},{"pmid":"20956979","id":"PMC_20956979","title":"Dysbindin-1 modulates prefrontal cortical activity and schizophrenia-like behaviors via dopamine/D2 pathways.","date":"2010","source":"Molecular psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/20956979","citation_count":117,"is_preprint":false},{"pmid":"17989303","id":"PMC_17989303","title":"Evidence that the BLOC-1 protein dysbindin modulates dopamine D2 receptor internalization and signaling but not D1 internalization.","date":"2007","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/17989303","citation_count":113,"is_preprint":false},{"pmid":"19349376","id":"PMC_19349376","title":"TRIM32 is an E3 ubiquitin ligase for dysbindin.","date":"2009","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/19349376","citation_count":112,"is_preprint":false},{"pmid":"17961984","id":"PMC_17961984","title":"Reduced DTNBP1 (dysbindin-1) mRNA in the hippocampal formation of schizophrenia patients.","date":"2007","source":"Schizophrenia research","url":"https://pubmed.ncbi.nlm.nih.gov/17961984","citation_count":110,"is_preprint":false},{"pmid":"18774265","id":"PMC_18774265","title":"Dysbindin deficiency in sandy mice causes reduction of snapin and displays behaviors related to schizophrenia.","date":"2008","source":"Schizophrenia research","url":"https://pubmed.ncbi.nlm.nih.gov/18774265","citation_count":105,"is_preprint":false},{"pmid":"18945333","id":"PMC_18945333","title":"Impaired long-term memory retention and working memory in sdy mutant mice with a deletion in Dtnbp1, a susceptibility gene for schizophrenia.","date":"2008","source":"Molecular brain","url":"https://pubmed.ncbi.nlm.nih.gov/18945333","citation_count":98,"is_preprint":false},{"pmid":"19617633","id":"PMC_19617633","title":"Dysbindin-1 in dorsolateral prefrontal cortex of schizophrenia cases is reduced in an isoform-specific manner unrelated to dysbindin-1 mRNA expression.","date":"2009","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/19617633","citation_count":98,"is_preprint":false},{"pmid":"21035792","id":"PMC_21035792","title":"Reduced dysbindin expression mediates N-methyl-D-aspartate receptor hypofunction and impaired working memory performance.","date":"2010","source":"Biological psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/21035792","citation_count":87,"is_preprint":false},{"pmid":"16513878","id":"PMC_16513878","title":"Dysbindin genotype and negative symptoms in schizophrenia.","date":"2006","source":"The American journal of psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/16513878","citation_count":87,"is_preprint":false},{"pmid":"19955431","id":"PMC_19955431","title":"Dysbindin regulates hippocampal LTP by controlling NMDA receptor surface expression.","date":"2009","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/19955431","citation_count":86,"is_preprint":false},{"pmid":"16166606","id":"PMC_16166606","title":"Is the dysbindin gene (DTNBP1) a susceptibility gene for schizophrenia?","date":"2005","source":"Schizophrenia bulletin","url":"https://pubmed.ncbi.nlm.nih.gov/16166606","citation_count":81,"is_preprint":false},{"pmid":"20531346","id":"PMC_20531346","title":"Dysbindin-1, WAVE2 and Abi-1 form a complex that regulates dendritic spine formation.","date":"2010","source":"Molecular psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/20531346","citation_count":81,"is_preprint":false},{"pmid":"18555792","id":"PMC_18555792","title":"Behavioral abnormalities and dopamine reductions in sdy mutant mice with a deletion in Dtnbp1, a susceptibility gene for schizophrenia.","date":"2008","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/18555792","citation_count":81,"is_preprint":false},{"pmid":"19641486","id":"PMC_19641486","title":"Dysbindin modulates prefrontal cortical glutamatergic circuits and working memory function in mice.","date":"2009","source":"Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/19641486","citation_count":79,"is_preprint":false},{"pmid":"15820225","id":"PMC_15820225","title":"Bipolar disorder and polymorphisms in the dysbindin gene (DTNBP1).","date":"2005","source":"Biological psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/15820225","citation_count":77,"is_preprint":false},{"pmid":"12591580","id":"PMC_12591580","title":"No evidence for association of the dysbindin gene [DTNBP1] with schizophrenia in an Irish population-based study.","date":"2003","source":"Schizophrenia research","url":"https://pubmed.ncbi.nlm.nih.gov/12591580","citation_count":73,"is_preprint":false},{"pmid":"16407900","id":"PMC_16407900","title":"DTNBP1 (dysbindin) gene variants modulate prefrontal brain function in healthy individuals.","date":"2006","source":"Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/16407900","citation_count":72,"is_preprint":false},{"pmid":"17033966","id":"PMC_17033966","title":"Analysis of high-resolution HapMap of DTNBP1 (Dysbindin) suggests no consistency between reported common variant associations and schizophrenia.","date":"2006","source":"American journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/17033966","citation_count":71,"is_preprint":false},{"pmid":"17408693","id":"PMC_17408693","title":"Association of schizophrenia with DTNBP1 but not with DAO, DAOA, NRG1 and RGS4 nor their genetic interaction.","date":"2007","source":"Journal of psychiatric research","url":"https://pubmed.ncbi.nlm.nih.gov/17408693","citation_count":67,"is_preprint":false},{"pmid":"21390302","id":"PMC_21390302","title":"Synaptic dysbindin-1 reductions in schizophrenia occur in an isoform-specific manner indicating their subsynaptic location.","date":"2011","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/21390302","citation_count":66,"is_preprint":false},{"pmid":"16283082","id":"PMC_16283082","title":"Dysbindin (DTNBP1, 6p22.3) is associated with childhood-onset psychosis and endophenotypes measured by the Premorbid Adjustment Scale (PAS).","date":"2005","source":"Journal of autism and developmental disorders","url":"https://pubmed.ncbi.nlm.nih.gov/16283082","citation_count":65,"is_preprint":false},{"pmid":"21520000","id":"PMC_21520000","title":"Cell biology of the BLOC-1 complex subunit dysbindin, a schizophrenia susceptibility gene.","date":"2011","source":"Molecular neurobiology","url":"https://pubmed.ncbi.nlm.nih.gov/21520000","citation_count":64,"is_preprint":false},{"pmid":"18984010","id":"PMC_18984010","title":"Behavioral characterization of dysbindin-1 deficient sandy mice.","date":"2008","source":"Behavioural brain research","url":"https://pubmed.ncbi.nlm.nih.gov/18984010","citation_count":64,"is_preprint":false},{"pmid":"21531389","id":"PMC_21531389","title":"Convergence of two independent mental disease genes on the protein level: recruitment of dysbindin to cell-invasive disrupted-in-schizophrenia 1 aggresomes.","date":"2011","source":"Biological psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/21531389","citation_count":64,"is_preprint":false},{"pmid":"21504412","id":"PMC_21504412","title":"Dysbindin-containing complexes and their proposed functions in brain: from zero to (too) many in a decade.","date":"2011","source":"ASN neuro","url":"https://pubmed.ncbi.nlm.nih.gov/21504412","citation_count":63,"is_preprint":false},{"pmid":"12878699","id":"PMC_12878699","title":"Abnormal dysbindin expression in cerebellar mossy fiber synapses in the mdx mouse model of Duchenne muscular dystrophy.","date":"2003","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/12878699","citation_count":62,"is_preprint":false},{"pmid":"21998198","id":"PMC_21998198","title":"The schizophrenia susceptibility factor dysbindin and its associated complex sort cargoes from cell bodies to the synapse.","date":"2011","source":"Molecular biology of the cell","url":"https://pubmed.ncbi.nlm.nih.gov/21998198","citation_count":61,"is_preprint":false},{"pmid":"16448387","id":"PMC_16448387","title":"Reinvestigation of the dysbindin subunit of BLOC-1 (biogenesis of lysosome-related organelles complex-1) as a dystrobrevin-binding protein.","date":"2006","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/16448387","citation_count":60,"is_preprint":false},{"pmid":"26285059","id":"PMC_26285059","title":"Antipsychotic drugs attenuate aberrant DNA methylation of DTNBP1 (dysbindin) promoter in saliva and post-mortem brain of patients with schizophrenia and Psychotic bipolar disorder.","date":"2015","source":"American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/26285059","citation_count":58,"is_preprint":false},{"pmid":"20174469","id":"PMC_20174469","title":"Dysbindin promotes the post-endocytic sorting of G protein-coupled receptors to lysosomes.","date":"2010","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/20174469","citation_count":56,"is_preprint":false},{"pmid":"24145376","id":"PMC_24145376","title":"Epistatic interaction between COMT and DTNBP1 modulates prefrontal function in mice and in humans.","date":"2013","source":"Molecular psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/24145376","citation_count":55,"is_preprint":false},{"pmid":"14688250","id":"PMC_14688250","title":"Myospryn is a novel binding partner for dysbindin in muscle.","date":"2003","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/14688250","citation_count":55,"is_preprint":false},{"pmid":"20302821","id":"PMC_20302821","title":"The sandy (sdy) mouse: a dysbindin-1 mutant relevant to schizophrenia research.","date":"2009","source":"Progress in brain research","url":"https://pubmed.ncbi.nlm.nih.gov/20302821","citation_count":54,"is_preprint":false},{"pmid":"17945199","id":"PMC_17945199","title":"Early visual processing deficits in dysbindin-associated schizophrenia.","date":"2007","source":"Biological psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/17945199","citation_count":53,"is_preprint":false},{"pmid":"21502952","id":"PMC_21502952","title":"Dysbindin-1, a schizophrenia-related protein, facilitates neurite outgrowth by promoting the transcriptional activity of p53.","date":"2011","source":"Molecular psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/21502952","citation_count":51,"is_preprint":false},{"pmid":"17445278","id":"PMC_17445278","title":"Association between the DTNBP1 gene and intelligence: a case-control study in young patients with schizophrenia and related disorders and unaffected siblings.","date":"2007","source":"Behavioral and brain functions : BBF","url":"https://pubmed.ncbi.nlm.nih.gov/17445278","citation_count":51,"is_preprint":false},{"pmid":"17618940","id":"PMC_17618940","title":"Dysbindin (DTNBP1) and the biogenesis of lysosome-related organelles complex 1 (BLOC-1): main and epistatic gene effects are potential contributors to schizophrenia susceptibility.","date":"2007","source":"Biological psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/17618940","citation_count":48,"is_preprint":false},{"pmid":"27091610","id":"PMC_27091610","title":"COMT, BDNF, and DTNBP1 polymorphisms and cognitive functions in patients with brain tumors.","date":"2016","source":"Neuro-oncology","url":"https://pubmed.ncbi.nlm.nih.gov/27091610","citation_count":47,"is_preprint":false},{"pmid":"17300918","id":"PMC_17300918","title":"The role of DTNBP1, NRG1, and AKT1 in the genetics of schizophrenia in Finland.","date":"2007","source":"Schizophrenia research","url":"https://pubmed.ncbi.nlm.nih.gov/17300918","citation_count":46,"is_preprint":false},{"pmid":"22049342","id":"PMC_22049342","title":"Schizophrenia susceptibility gene dysbindin regulates glutamatergic and dopaminergic functions via distinctive mechanisms in Drosophila.","date":"2011","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/22049342","citation_count":45,"is_preprint":false},{"pmid":"25568125","id":"PMC_25568125","title":"Gene dosage in the dysbindin schizophrenia susceptibility network differentially affect synaptic function and plasticity.","date":"2015","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/25568125","citation_count":45,"is_preprint":false},{"pmid":"16463116","id":"PMC_16463116","title":"Effect of antipsychotic drugs on DISC1 and dysbindin expression in mouse frontal cortex and hippocampus.","date":"2006","source":"Journal of neural transmission (Vienna, Austria : 1996)","url":"https://pubmed.ncbi.nlm.nih.gov/16463116","citation_count":45,"is_preprint":false},{"pmid":"17555717","id":"PMC_17555717","title":"The dysbindin gene (DTNBP1) is associated with methamphetamine psychosis.","date":"2007","source":"Biological psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/17555717","citation_count":43,"is_preprint":false},{"pmid":"19077176","id":"PMC_19077176","title":"Variation in the dysbindin gene and normal cognitive function in three independent population samples.","date":"2008","source":"Genes, brain, and behavior","url":"https://pubmed.ncbi.nlm.nih.gov/19077176","citation_count":42,"is_preprint":false},{"pmid":"29891954","id":"PMC_29891954","title":"Variations in Dysbindin-1 are associated with cognitive response to antipsychotic drug treatment.","date":"2018","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/29891954","citation_count":40,"is_preprint":false},{"pmid":"28465353","id":"PMC_28465353","title":"TRIM24 protein promotes and TRIM32 protein inhibits cardiomyocyte hypertrophy via regulation of dysbindin protein levels.","date":"2017","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/28465353","citation_count":39,"is_preprint":false},{"pmid":"28937620","id":"PMC_28937620","title":"Dysbindin-1 Involvement in the Etiology of Schizophrenia.","date":"2017","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/28937620","citation_count":38,"is_preprint":false},{"pmid":"17290445","id":"PMC_17290445","title":"Association study of dysbindin gene with clinical and outcome measures in a representative cohort of Italian schizophrenic patients.","date":"2007","source":"American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/17290445","citation_count":38,"is_preprint":false},{"pmid":"29348419","id":"PMC_29348419","title":"Dysbindin links presynaptic proteasome function to homeostatic recruitment of low release probability vesicles.","date":"2018","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/29348419","citation_count":38,"is_preprint":false},{"pmid":"19094965","id":"PMC_19094965","title":"Dysbindin engages in c-Jun N-terminal kinase activity and cytoskeletal organization.","date":"2008","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/19094965","citation_count":37,"is_preprint":false},{"pmid":"31492942","id":"PMC_31492942","title":"The epistatic interaction between the dopamine D3 receptor and dysbindin-1 modulates higher-order cognitive functions in mice and humans.","date":"2019","source":"Molecular psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/31492942","citation_count":37,"is_preprint":false},{"pmid":"15211634","id":"PMC_15211634","title":"Linkage disequlibrium in the DTNBP1 (dysbindin) gene region and on chromosome 1p36 among psychotic patients from a genetic isolate in Israel: findings from identity by descent haplotype sharing analysis.","date":"2004","source":"American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/15211634","citation_count":36,"is_preprint":false},{"pmid":"23750231","id":"PMC_23750231","title":"MeCP2 regulates the synaptic expression of a Dysbindin-BLOC-1 network component in mouse brain and human induced pluripotent stem cell-derived neurons.","date":"2013","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/23750231","citation_count":35,"is_preprint":false},{"pmid":"20236384","id":"PMC_20236384","title":"Cytosolic protein interactions of the schizophrenia susceptibility gene dysbindin.","date":"2010","source":"Journal of neurochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/20236384","citation_count":34,"is_preprint":false},{"pmid":"17476109","id":"PMC_17476109","title":"DTNBP1 (Dystrobrevin binding protein 1) and schizophrenia: association evidence in the 3' end of the gene.","date":"2007","source":"Human heredity","url":"https://pubmed.ncbi.nlm.nih.gov/17476109","citation_count":34,"is_preprint":false},{"pmid":"19439994","id":"PMC_19439994","title":"DTNBP1, NRG1, DAOA, DAO and GRM3 polymorphisms and schizophrenia: an association study.","date":"2009","source":"Neuropsychobiology","url":"https://pubmed.ncbi.nlm.nih.gov/19439994","citation_count":32,"is_preprint":false},{"pmid":"15331232","id":"PMC_15331232","title":"Schizophrenia genetics: dysbindin under the microscope.","date":"2004","source":"Trends in neurosciences","url":"https://pubmed.ncbi.nlm.nih.gov/15331232","citation_count":31,"is_preprint":false},{"pmid":"19089808","id":"PMC_19089808","title":"Association of the dystrobrevin binding protein 1 gene (DTNBP1) in a bipolar case-control study (BACCS).","date":"2009","source":"American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/19089808","citation_count":31,"is_preprint":false},{"pmid":"19800201","id":"PMC_19800201","title":"The dystrobrevin binding protein 1 (DTNBP1) gene is associated with schizophrenia in the Irish Case Control Study of Schizophrenia (ICCSS) sample.","date":"2009","source":"Schizophrenia research","url":"https://pubmed.ncbi.nlm.nih.gov/19800201","citation_count":31,"is_preprint":false},{"pmid":"24713699","id":"PMC_24713699","title":"Mutations in the BLOC-1 subunits dysbindin and muted generate divergent and dosage-dependent phenotypes.","date":"2014","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/24713699","citation_count":30,"is_preprint":false},{"pmid":"16876895","id":"PMC_16876895","title":"Association study of the dysbindin (DTNBP1) gene in schizophrenia from the Japanese population.","date":"2006","source":"Neuroscience research","url":"https://pubmed.ncbi.nlm.nih.gov/16876895","citation_count":30,"is_preprint":false},{"pmid":"26386481","id":"PMC_26386481","title":"Regulation of Brain-Derived Neurotrophic Factor Exocytosis and Gamma-Aminobutyric Acidergic Interneuron Synapse by the Schizophrenia Susceptibility Gene Dysbindin-1.","date":"2015","source":"Biological psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/26386481","citation_count":30,"is_preprint":false},{"pmid":"21130223","id":"PMC_21130223","title":"Meta-analysis of genetic variation in DTNBP1 and general cognitive ability.","date":"2010","source":"Biological psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/21130223","citation_count":29,"is_preprint":false},{"pmid":"20615671","id":"PMC_20615671","title":"Analysis of HapMap tag-SNPs in dysbindin (DTNBP1) reveals evidence of consistent association with schizophrenia.","date":"2010","source":"European psychiatry : the journal of the Association of European Psychiatrists","url":"https://pubmed.ncbi.nlm.nih.gov/20615671","citation_count":29,"is_preprint":false},{"pmid":"17604607","id":"PMC_17604607","title":"Association study between the dystrobrevin binding protein 1 gene (DTNBP1) and schizophrenia: a meta-analysis.","date":"2007","source":"Schizophrenia research","url":"https://pubmed.ncbi.nlm.nih.gov/17604607","citation_count":28,"is_preprint":false},{"pmid":"25972187","id":"PMC_25972187","title":"The N-ethylmaleimide-sensitive factor and dysbindin interact to modulate synaptic plasticity.","date":"2015","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/25972187","citation_count":28,"is_preprint":false},{"pmid":"24446171","id":"PMC_24446171","title":"Dysbindin-1 loss compromises NMDAR-dependent synaptic plasticity and contextual fear conditioning.","date":"2013","source":"Hippocampus","url":"https://pubmed.ncbi.nlm.nih.gov/24446171","citation_count":28,"is_preprint":false},{"pmid":"24385487","id":"PMC_24385487","title":"Dysbindin is a potent inducer of RhoA-SRF-mediated cardiomyocyte hypertrophy.","date":"2013","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/24385487","citation_count":28,"is_preprint":false},{"pmid":"23473812","id":"PMC_23473812","title":"Potential molecular mechanisms for decreased synaptic glutamate release in dysbindin-1 mutant mice.","date":"2013","source":"Schizophrenia research","url":"https://pubmed.ncbi.nlm.nih.gov/23473812","citation_count":28,"is_preprint":false},{"pmid":"25297099","id":"PMC_25297099","title":"The schizophrenia susceptibility gene dysbindin regulates dendritic spine dynamics.","date":"2014","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/25297099","citation_count":27,"is_preprint":false},{"pmid":"27927957","id":"PMC_27927957","title":"The Proteome of BLOC-1 Genetic Defects Identifies the Arp2/3 Actin Polymerization Complex to Function Downstream of the Schizophrenia Susceptibility Factor Dysbindin at the Synapse.","date":"2016","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/27927957","citation_count":27,"is_preprint":false},{"pmid":"19428785","id":"PMC_19428785","title":"Direct interaction of Dysbindin with the AP-3 complex via its mu subunit.","date":"2009","source":"Neurochemistry international","url":"https://pubmed.ncbi.nlm.nih.gov/19428785","citation_count":26,"is_preprint":false},{"pmid":"25157109","id":"PMC_25157109","title":"Dysbindin-1C is required for the survival of hilar mossy cells and the maturation of adult newborn neurons in dentate gyrus.","date":"2014","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/25157109","citation_count":26,"is_preprint":false},{"pmid":"25859193","id":"PMC_25859193","title":"Loss of dysbindin-1, a risk gene for schizophrenia, leads to impaired group 1 metabotropic glutamate receptor function in mice.","date":"2015","source":"Frontiers in behavioral neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/25859193","citation_count":26,"is_preprint":false},{"pmid":"19496996","id":"PMC_19496996","title":"Association between the dysbindin gene (DTNBP1) and cognitive functions in Japanese subjects.","date":"2009","source":"Psychiatry and clinical neurosciences","url":"https://pubmed.ncbi.nlm.nih.gov/19496996","citation_count":25,"is_preprint":false},{"pmid":"17192893","id":"PMC_17192893","title":"Effect of 5-haplotype of dysbindin gene (DTNBP1) polymorphisms for the susceptibility to bipolar I disorder.","date":"2007","source":"American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/17192893","citation_count":25,"is_preprint":false},{"pmid":"19573021","id":"PMC_19573021","title":"Proteomic analysis reveals novel binding partners of dysbindin, a schizophrenia-related protein.","date":"2009","source":"Journal of neurochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/19573021","citation_count":25,"is_preprint":false},{"pmid":"26199316","id":"PMC_26199316","title":"Neuronal copper homeostasis susceptibility by genetic defects in dysbindin, a schizophrenia susceptibility factor.","date":"2015","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/26199316","citation_count":25,"is_preprint":false},{"pmid":"23364359","id":"PMC_23364359","title":"Microsatellite markers as a rapid approach for autozygosity mapping in Hermansky-Pudlak syndrome: identification of the second HPS7 mutation in a patient presenting late in life.","date":"2013","source":"Thrombosis and haemostasis","url":"https://pubmed.ncbi.nlm.nih.gov/23364359","citation_count":25,"is_preprint":false},{"pmid":"19065121","id":"PMC_19065121","title":"Dysbindin gene (DTNBP1) in major depression: association with clinical response to selective serotonin reuptake inhibitors.","date":"2009","source":"Pharmacogenetics and genomics","url":"https://pubmed.ncbi.nlm.nih.gov/19065121","citation_count":23,"is_preprint":false},{"pmid":"25697573","id":"PMC_25697573","title":"Dysbindin (DTNBP1) variants are associated with hallucinations in schizophrenia.","date":"2015","source":"European psychiatry : the journal of the Association of European Psychiatrists","url":"https://pubmed.ncbi.nlm.nih.gov/25697573","citation_count":23,"is_preprint":false},{"pmid":"19449336","id":"PMC_19449336","title":"DTNBP1 is associated with imaging phenotypes in schizophrenia.","date":"2009","source":"Human brain mapping","url":"https://pubmed.ncbi.nlm.nih.gov/19449336","citation_count":23,"is_preprint":false},{"pmid":"19369910","id":"PMC_19369910","title":"The efficacies of clozapine and haloperidol in refractory schizophrenia are related to DTNBP1 variation.","date":"2009","source":"Pharmacogenetics and genomics","url":"https://pubmed.ncbi.nlm.nih.gov/19369910","citation_count":23,"is_preprint":false},{"pmid":"16959423","id":"PMC_16959423","title":"The dysbindin gene (DTNBP1) and schizophrenia: no support for an association in the Korean population.","date":"2006","source":"Neuroscience letters","url":"https://pubmed.ncbi.nlm.nih.gov/16959423","citation_count":22,"is_preprint":false},{"pmid":"20921223","id":"PMC_20921223","title":"Nucleocytoplasmic shuttling of dysbindin-1, a schizophrenia-related protein, regulates synapsin I expression.","date":"2010","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/20921223","citation_count":22,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":48841,"output_tokens":9831,"usd":0.146994,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":20359,"output_tokens":5129,"usd":0.11501,"stage2_stop_reason":"end_turn"},"total_usd":0.262004,"stage1_batch_id":"msgbatch_01AsR7g8dGTEiEw9U83bJeWn","stage2_batch_id":"msgbatch_01YV5ZyxtFNUZEjxRcpd9jzb","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2001,\n      \"finding\": \"Dysbindin (DTNBP1) is a novel coiled-coil-containing protein that binds directly to alpha- and beta-dystrobrevin in muscle and brain, is co-immunoprecipitated with dystrophin and alpha-dystrobrevin (indicating DPC association in muscle), co-localizes with alpha-dystrobrevin at the sarcolemma, and is found in axon bundles and mossy fiber synaptic terminals in brain.\",\n      \"method\": \"Yeast two-hybrid screen, co-immunoprecipitation, immunolocalization\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — yeast two-hybrid plus reciprocal co-IP, replicated in multiple tissues; foundational identification paper\",\n      \"pmids\": [\"11316798\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"Dysbindin binds to myospryn, a novel 413-kDa muscle protein, and the two proteins co-immunoprecipitate from muscle extracts and are extensively co-localized, demonstrating a tissue-specific binding partner for dysbindin in muscle.\",\n      \"method\": \"Yeast two-hybrid screen, co-immunoprecipitation, co-localization immunofluorescence\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — yeast two-hybrid plus co-IP in native tissue, single lab\",\n      \"pmids\": [\"14688250\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"Overexpression of dysbindin in primary cortical neurons increases expression of presynaptic proteins SNAP25 and synapsin I and enhances extracellular glutamate release; siRNA knockdown reduces both presynaptic protein expression and glutamate release, indicating dysbindin regulates exocytotic glutamate release via upregulation of presynaptic machinery.\",\n      \"method\": \"Neuronal overexpression and siRNA knockdown, ELISA glutamate measurement, Western blotting\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — complementary gain- and loss-of-function in primary neurons, single lab\",\n      \"pmids\": [\"15345706\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"Dysbindin overexpression increases Akt phosphorylation and protects cortical neurons against serum deprivation-induced death via PI3-kinase–Akt signaling; these effects are blocked by the PI3-kinase inhibitor LY294002, and siRNA knockdown of dysbindin diminishes Akt phosphorylation and facilitates neuronal death.\",\n      \"method\": \"Neuronal overexpression and siRNA knockdown, pharmacological inhibition (LY294002), Western blotting for pAkt, cell viability assays\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — bidirectional manipulation plus pharmacological epistasis, single lab\",\n      \"pmids\": [\"15345706\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"Dysbindin-1 binds snapin in vitro and in brain; both proteins are concentrated in synaptic vesicle membrane fractions and less so in postsynaptic densities, with immunoelectron microscopy showing dysbindin-1 in synaptic vesicles of axospinous terminals and in postsynaptic densities and microtubules of hippocampal neurons.\",\n      \"method\": \"In vitro binding assay, tissue fractionation, co-immunoprecipitation, immunoelectron microscopy\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — in vitro binding plus native co-IP plus ultrastructural localization, multiple orthogonal methods\",\n      \"pmids\": [\"16980328\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"Dysbindin is a stable subunit of the BLOC-1 complex; within BLOC-1 its dystrobrevin-binding region (69-residue coiled-coil) is occupied by interactions with pallidin, snapin, and muted subunits. Recombinant dystrobrevin coiled-coil fragments fail to pull down endogenous BLOC-1 from brain or muscle, and immunoprecipitation of endogenous dysbindin from brain or muscle co-precipitates pallidin but not dystrobrevin isoforms, indicating that BLOC-1-assembled dysbindin is not a physiological dystrobrevin-binding partner.\",\n      \"method\": \"Yeast two-hybrid, recombinant protein binding assays, co-immunoprecipitation of endogenous proteins from brain and muscle\",\n      \"journal\": \"The Biochemical journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — reconstitution-level binding assays plus endogenous co-IP in multiple tissues, multiple orthogonal methods in one study\",\n      \"pmids\": [\"16448387\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"DTNBP1 siRNA knockdown decreases dysbindin protein, increases cell-surface D2 receptor (DRD2) levels, and blocks dopamine-induced DRD2 internalization in SH-SY5Y cells and rat primary cortical neurons; MUTED siRNA produces similar effects; DRD1 levels and internalization are unaffected. Enhanced DRD2 surface levels lead to increased quinpirole-induced reduction of CREB phosphorylation, demonstrating augmented intracellular signaling.\",\n      \"method\": \"siRNA knockdown, flow cytometry / immunofluorescence for surface receptor quantification, Western blotting for pCREB\",\n      \"journal\": \"The Journal of neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple cell types, reciprocal siRNA (DTNBP1 and MUTED), functional readout of downstream signaling, replicated in two cell systems\",\n      \"pmids\": [\"17989303\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"Loss of dysbindin in sandy (sdy) mice causes larger dense-core vesicle size, slower quantal release kinetics, lower release probability, and a smaller readily releasable vesicle pool in neuroendocrine cells and hippocampal synapses, indicating dysbindin regulates exocytosis and vesicle biogenesis.\",\n      \"method\": \"Amperometry, whole-cell patch clamp, electron microscopy in dysbindin-null (sdy) mice\",\n      \"journal\": \"The Journal of cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — three orthogonal biophysical methods in a genetic null model, single rigorous study\",\n      \"pmids\": [\"18504299\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"Dysbindin-null (sdy) mice have reduced dopamine (but not glutamate) levels in cerebral cortex, hippocampus, and hypothalamus, linking dysbindin deficiency to reduced forebrain dopaminergic transmission.\",\n      \"method\": \"Neurochemical quantification (HPLC) in dysbindin-null (sdy) mice brain regions\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct neurochemical measurement in genetic null, single lab, single method\",\n      \"pmids\": [\"18555792\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"In dysbindin-null (sdy) mice, steady-state snapin protein is reduced in hippocampus; a 30-residue peptide (amino acids 90–119) of dysbindin mediates the interaction with snapin, and its loss destabilizes snapin leading to abnormal neurotransmission.\",\n      \"method\": \"Western blotting in sdy mice, peptide binding/interaction mapping\",\n      \"journal\": \"Schizophrenia research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — domain mapping plus in vivo consequence in null mice, single lab\",\n      \"pmids\": [\"18774265\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"TRIM32 is an E3 ubiquitin ligase that binds dysbindin via yeast two-hybrid, ubiquitinates it to augment its degradation, and siRNA knockdown of TRIM32 elevates dysbindin levels. LGMD2H/STM-associated mutations D487N and R394H impair ubiquitin ligase activity toward dysbindin while retaining dysbindin-binding ability; D487N can bind dysbindin and its E2 but is defective in monoubiquitination.\",\n      \"method\": \"Yeast two-hybrid, in vitro/cell-based ubiquitination assays, siRNA knockdown, Western blotting, co-immunoprecipitation\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — multiple orthogonal biochemical methods including direct ubiquitination assay plus mutagenesis of disease alleles, single rigorous study\",\n      \"pmids\": [\"19349376\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Drosophila dysbindin is required presynaptically for retrograde homeostatic modulation of neurotransmission in a dose-dependent manner, functioning downstream of or independently of calcium influx, as established by an electrophysiology-based forward genetic screen at the neuromuscular junction.\",\n      \"method\": \"Forward genetic screen, electrophysiology (mEJP, EJP recording), genetic epistasis with calcium channel mutations\",\n      \"journal\": \"Science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — unbiased forward screen followed by electrophysiological and epistasis analysis in Drosophila ortholog\",\n      \"pmids\": [\"19965435\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"In dysbindin-knockout (dys−/−) mice, D2 receptor (but not D1) surface expression is robustly increased due to enhanced recycling and insertion rather than reduced endocytosis; fast-spiking GABAergic interneurons in PFC and striatum show decreased excitability; inhibitory input to PFC pyramidal neurons is decreased; and D2 agonist produces a more pronounced increase in interneuron firing in dys−/− compared to wild-type.\",\n      \"method\": \"Cell imaging, biochemical fractionation, whole-cell electrophysiology, receptor trafficking assays in genetic knockout mice\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal methods (imaging, biochemistry, electrophysiology) in a genetic null model across multiple cell types\",\n      \"pmids\": [\"19887632\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Dysbindin controls hippocampal LTP by selectively reducing surface expression of NR2A (but not NR2B) NMDA receptor subunits; dysbindin-null hippocampal neurons show increased surface NR2A by imaging and biotinylation, increased NR2A-mediated synaptic currents, and enhanced LTP without changes in basal transmission, AMPA receptor currents, or LTD.\",\n      \"method\": \"Fluorescence imaging, surface biotinylation, whole-cell electrophysiology (patch clamp), LTP/LTD field recordings in hippocampal slices from genetic null mice\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — multiple orthogonal methods (imaging, biochemistry, electrophysiology, plasticity assays) in genetic null, single rigorous study\",\n      \"pmids\": [\"19955431\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Dysbindin-null mice show reduced paired-pulse facilitation and reduced evoked and miniature excitatory post-synaptic currents in deep-layer PFC pyramidal neurons, indicating a presynaptic deficit in glutamatergic transmission that is associated with impaired spatial working memory.\",\n      \"method\": \"Whole-cell patch clamp recordings in PFC slices, behavioral spatial working memory task in genetic null mice\",\n      \"journal\": \"Neuropsychopharmacology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — electrophysiology plus behavior in genetic null, single lab\",\n      \"pmids\": [\"19641486\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Direct interaction between dysbindin and the AP-3 complex is mediated through the mu subunit of AP-3; dysbindin partially co-localizes with AP-3 in hippocampal CA1/CA3 and at presynaptic terminals and growth cones; dysbindin suppression reduces presynaptic protein expression and glutamate release.\",\n      \"method\": \"Co-immunoprecipitation, in vitro binding assay, immunofluorescence co-localization, siRNA knockdown with glutamate release assay\",\n      \"journal\": \"Neurochemistry international\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct binding demonstrated in vitro plus native co-IP plus functional siRNA, single lab\",\n      \"pmids\": [\"19428785\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Proteomics of dysbindin-interacting proteins from rat brain identifies Munc18-1 as a binding partner; Munc18-1 co-immunoprecipitates with dysbindin from rat brain lysate, interacts directly in vitro, and co-localizes with dysbindin at presynaptic terminals in cultured hippocampal neurons.\",\n      \"method\": \"Affinity chromatography, MALDI-TOF/LC-MS/MS proteomics, co-immunoprecipitation, in vitro binding assay, immunofluorescence\",\n      \"journal\": \"Journal of neurochemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — mass spectrometry identification confirmed by co-IP and in vitro binding, single lab\",\n      \"pmids\": [\"19573021\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Cytosolic immunoprecipitation/mass spectrometry of dysbindin identifies novel interactions with members of the exocyst, dynactin, and chaperonin containing T-complex protein (CCT) complexes, in addition to confirming all BLOC-1 and AP-3 subunit interactions.\",\n      \"method\": \"Co-immunoprecipitation, mass spectrometry, Western blot validation in mammalian cells\",\n      \"journal\": \"Journal of neurochemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — MS-based interactome with validation by Western blot, single lab\",\n      \"pmids\": [\"20236384\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Dysbindin knockdown in HEK293 and HeLa cells specifically reduces post-endocytic lysosomal trafficking of internalized D2 receptors (and delta opioid receptors) without affecting receptor endocytosis; dysbindin co-immunoprecipitates with GASP-1 and HRS (ESCRT component), suggesting it promotes lysosomal sorting of specific GPCRs.\",\n      \"method\": \"RNA interference, immunochemistry, biochemical trafficking assays, co-immunoprecipitation in non-neuronal cells\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple receptor substrates tested, co-IP of interaction partners, single lab\",\n      \"pmids\": [\"20174469\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Dysbindin-1 and WAVE2 and Abi-1 form a ternary complex; dysbindin-1 promotes the binding of WAVE2 to Abi-1; siRNA knockdown of dysbindin-1 in hippocampal neurons leads to elongated immature dendritic protrusions, indicating a role in dendritic spine morphogenesis.\",\n      \"method\": \"Co-immunoprecipitation, yeast two-hybrid, RNAi knockdown with morphological analysis of dendritic spines\",\n      \"journal\": \"Molecular psychiatry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — complex formation demonstrated by co-IP plus loss-of-function morphological phenotype, single lab\",\n      \"pmids\": [\"20531346\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Dysbindin-1 is a nucleocytoplasmic shuttling protein with a functional nuclear export signal; inhibition of CRM1/exportin-1-mediated nuclear export (leptomycin B) causes nuclear accumulation of dysbindin-1; nucleocytoplasmic shuttling regulates synapsin I expression; dysbindin-1-null (sdy) mice have reduced synapsin I protein and mRNA.\",\n      \"method\": \"Leptomycin B treatment, nuclear export signal mutagenesis, subcellular fractionation, Western blotting in sandy mice\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — pharmacological nuclear export block plus mutagenesis plus in vivo null mouse confirmation, single lab\",\n      \"pmids\": [\"20921223\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Dysbindin deficiency in dys−/− mice is associated with reduced NMDA-evoked currents in PFC pyramidal neurons and decreased NR1 subunit expression; the degree of NR1 expression correlates with spatial working memory performance.\",\n      \"method\": \"Whole-cell recordings in PFC slices, quantitative RT-PCR for NR1, behavioral spatial working memory testing in genetic null mice\",\n      \"journal\": \"Biological psychiatry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — electrophysiology plus molecular quantification plus behavior in genetic null, single lab\",\n      \"pmids\": [\"21035792\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Dysbindin-1 disruption in dys−/− mice reduces CaMKII and CaMKKβ expression in mPFC; chronic D2 agonist treatment reproduces these protein expression changes; dys−/− pyramidal neurons are hyperexcitable at baseline but hypoexcitable following D2 stimulation.\",\n      \"method\": \"Western blotting, in vivo electrophysiology, pharmacological D2 manipulation in genetic knockout mice\",\n      \"journal\": \"Molecular psychiatry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple biochemical and electrophysiological methods in genetic null with pharmacological epistasis, single lab\",\n      \"pmids\": [\"20956979\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"DISC1 aggresomes recruit dysbindin via a direct interaction mapped to DISC1 residues 316–597 and dysbindin residues 82–173; direct interaction between soluble DISC1 and dysbindin is demonstrated in a cell-free system using E. coli-expressed proteins; co-aggregation of both proteins is found in postmortem brains of mental disease patients but not healthy controls.\",\n      \"method\": \"Cell transfection aggresome assay, E. coli recombinant protein binding assay, postmortem brain biochemical fractionation and co-immunoprecipitation\",\n      \"journal\": \"Biological psychiatry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1–2 / Moderate — cell-free direct binding plus domain mapping plus postmortem brain confirmation, single lab\",\n      \"pmids\": [\"21531389\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Dysbindin assembles into BLOC-1, which interacts with AP-3; BLOC-1/AP-3 deficiencies reduce PI4KIIα content in the dentate gyrus of dysbindin-null mice due to a failure to traffic PI4KIIα from cell bodies to neurites, defining a BLOC-1/AP-3-dependent vesicle transport mechanism for cargo sorting from neuronal cell bodies to nerve terminals.\",\n      \"method\": \"Co-purification, AP-3 and BLOC-1 knockout mouse analysis, immunofluorescence in primary neurons and PC12 cells, AP-3 sorting motif mutagenesis\",\n      \"journal\": \"Molecular biology of the cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple genetic models (dysbindin null, AP-3 null), biochemical co-purification, mutagenesis of sorting motif, multiple orthogonal approaches\",\n      \"pmids\": [\"21998198\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Dysbindin-1 isoforms show distinct subsynaptic localizations: dysbindin-1B is predominantly associated with synaptic vesicles, while dysbindin-1A and -1C are predominantly in postsynaptic densities, as determined by Western blotting of subsynaptic tissue fractions.\",\n      \"method\": \"Subcellular fractionation, Western blotting of subsynaptic fractions from multiple brain areas\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — systematic fractionation of multiple brain regions, single lab\",\n      \"pmids\": [\"21390302\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Dysbindin-1 recruits necdin to the cytoplasm, attenuating necdin's repression of p53 transcriptional activity; dysbindin-1 knockdown reduces p53 target genes coronin 1b and rab13, impairing neurite outgrowth; overexpression of p53 rescues neurite outgrowth blocked by dysbindin-1 knockdown; sandy mouse neurons show reduced p21, coronin 1b, and rab13 and neurite outgrowth defects.\",\n      \"method\": \"Yeast two-hybrid, co-immunoprecipitation, siRNA knockdown, p53 reporter assay, neurite outgrowth imaging in primary neurons from sdy mice\",\n      \"journal\": \"Molecular psychiatry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple complementary methods including reporter assay, rescue experiment, and in vivo null mouse validation, single lab\",\n      \"pmids\": [\"21502952\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Drosophila dysbindin (Ddysb) reduced in presynaptic neurons suppresses glutamatergic synaptic transmission causing memory impairment; reduced Ddysb in glial cells causes hyperdopaminergic activity by altering expression of the dopamine metabolic enzyme Ebony, leading to abnormal locomotion.\",\n      \"method\": \"Cell-type-specific RNAi (neuronal vs. glial), electrophysiology, behavioral assays, Ebony expression analysis in Drosophila\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — cell-type-specific genetic dissection with electrophysiology and behavioral and molecular readouts, mechanistically rigorous\",\n      \"pmids\": [\"22049342\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Dysbindin binds RhoA and activates RhoA-SRF and MEK1-ERK1 signaling pathways in cardiomyocytes, inducing cardiac hypertrophy; RhoA was identified as a novel dysbindin-binding partner by yeast two-hybrid and confirmed by co-immunoprecipitation.\",\n      \"method\": \"Yeast two-hybrid, co-immunoprecipitation, SRF luciferase reporter assay, Western blotting, morphological hypertrophy measurements in neonatal rat cardiomyocytes\",\n      \"journal\": \"The Journal of cell biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — yeast two-hybrid plus co-IP plus functional reporter, single lab\",\n      \"pmids\": [\"24385487\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Dysbindin-1 null (sdy) mice show reduced NMDAR-dependent LTP in hippocampal CA1 that is rescued by exogenous glycine (NMDAR co-agonist), indicating impaired NMDAR function underlies the plasticity deficit; homozygous null mice also show deficits in contextual fear conditioning.\",\n      \"method\": \"Hippocampal slice field recordings (LTP), pharmacological rescue with glycine, contextual fear conditioning in genetic null mice\",\n      \"journal\": \"Hippocampus\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — electrophysiology with pharmacological rescue plus behavioral phenotype in genetic null, single lab\",\n      \"pmids\": [\"24446171\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Dysbindin-1 null mice have a decreased readily releasable pool of synaptic vesicles, decreased quantal size, decreased release probability, deficits in endo- and exocytosis rates, decreased intracellular Ca2+, reduced expression of L- and N-type Ca2+ channels, and reduced expression of synaptic vesicle trafficking and priming proteins in PFC.\",\n      \"method\": \"Electrophysiology, vesicle imaging, calcium imaging, Western blotting in dysbindin-null mice\",\n      \"journal\": \"Schizophrenia research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple physiological and biochemical methods in genetic null, single lab\",\n      \"pmids\": [\"23473812\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Dysbindin-1C isoform (but not -1A) is specifically localized to hilar glutamatergic mossy cells in dentate gyrus; loss of dysbindin-1C (in sdy mice) reduces mossy cell numbers and causes delayed maturation of adult-born neurons, whereas muted mice (in which dysbindin-1A is destabilized but -1C is intact) do not show this phenotype.\",\n      \"method\": \"Immunohistochemistry for isoform-specific localization, comparison of sdy and muted mouse hippocampal phenotypes, BrdU/doublecortin labeling for neurogenesis\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — isoform-specific localization plus comparative genetic mouse models, single lab\",\n      \"pmids\": [\"25157109\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Dysbindin-null neurons show hyperactive dendritic protrusion dynamics (increased formation, retraction, and conversion); CaMKIIα is required for mushroom/thin spine stabilization; the hyperactivity in dysbindin-null neurons is attributed in part to decreased CaMKIIα activity resulting from increased Abi1-mediated inhibition of CaMKIIα.\",\n      \"method\": \"Time-lapse live imaging of hippocampal neurons from dysbindin-null mice, CaMKIIα activity assays, Abi1 co-immunoprecipitation\",\n      \"journal\": \"The Journal of neuroscience\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — live-cell imaging plus mechanistic epistasis analysis, single lab\",\n      \"pmids\": [\"25297099\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Dysbindin-1 deficiency reduces BDNF exocytosis from cortical excitatory neurons (measured by TIRF microscopy); this reduction in BDNF release transsynaptically decreases the number of inhibitory synapses on excitatory neurons; exogenous BDNF rescues the inhibitory synaptic deficits caused by reduced dysbindin-1 in cultured neurons and slice cultures.\",\n      \"method\": \"TIRF microscopy (live-cell BDNF exocytosis imaging), whole-cell recordings, immunohistochemistry, exogenous BDNF rescue in cortical neurons and organotypic slices\",\n      \"journal\": \"Biological psychiatry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal methods (TIRF, electrophysiology, IHC, rescue experiment) establishing a mechanistic pathway, single rigorous study\",\n      \"pmids\": [\"26386481\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Dysbindin/BLOC-1 deficiency reduces expression of Arp2/3 complex subunits in neuronal cells, impairs actin dynamics in early endosomes, and Arp2/3, dysbindin, and BLOC-1 subunits biochemically and genetically interact in Drosophila to modulate synapse morphology and homeostatic plasticity.\",\n      \"method\": \"Quantitative mass spectrometry proteomics, Western blot validation, actin dynamics assay, co-immunoprecipitation, Drosophila genetic interaction (synapse morphology and electrophysiology)\",\n      \"journal\": \"The Journal of neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — unbiased proteomics confirmed by multiple methods plus genetic epistasis in Drosophila with electrophysiological phenotype\",\n      \"pmids\": [\"27927957\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Dysbindin/BLOC-1 genetically and biochemically interacts with the copper transporter ATP7A; BLOC-1-null mice show altered transcriptional profiles of copper-regulatory and dependent factors in hippocampus; dysbindin/BLOC-1 loss-of-function alleles increase susceptibility to toxic copper challenges in mammalian cells and Drosophila without changing basal copper content.\",\n      \"method\": \"Co-immunoprecipitation, transcriptomic analysis in BLOC-1-null mice, copper toxicity assays in cells and Drosophila, genetic interaction analysis\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — biochemical interaction plus multiple genetic models plus functional toxicity assays, single lab\",\n      \"pmids\": [\"26199316\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"N-ethylmaleimide-sensitive factor (NSF) protein levels are downregulated in dysbindin/BLOC-1-deficient cells; human dysbindin/BLOC-1 co-precipitates with NSF; in Drosophila, presynaptic expression of either dysbindin or NSF fully rescues the dysbindin-mutant failure of homeostatic synaptic plasticity.\",\n      \"method\": \"Proteome-wide screen, co-immunoprecipitation, Drosophila genetic rescue of homeostatic plasticity (electrophysiology)\",\n      \"journal\": \"The Journal of neuroscience\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — proteomics identification confirmed by co-IP plus genetic rescue in Drosophila electrophysiology, single lab\",\n      \"pmids\": [\"25972187\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"TRIM24 binds dysbindin (identified by yeast two-hybrid, confirmed by co-IP) and protects dysbindin from TRIM32-mediated degradation in cardiomyocytes; TRIM32 degrades dysbindin in cardiomyocytes (as in skeletal muscle), attenuating dysbindin-driven SRF signaling and hypertrophy; TRIM24 overexpression promotes dysbindin-dependent SRF activation and hypertrophy.\",\n      \"method\": \"Yeast two-hybrid, co-immunoprecipitation, co-immunostaining, Western blotting for dysbindin levels after TRIM24/TRIM32 manipulation, SRF luciferase reporter assay, cardiomyocyte hypertrophy measurements\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — yeast two-hybrid plus co-IP plus functional reporter assays, single lab\",\n      \"pmids\": [\"28465353\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Dysbindin regulates access to EGTA-sensitive (loosely coupled) synaptic vesicles; presynaptic proteasome inhibition potentiates release under baseline conditions but not during homeostatic plasticity, and this effect requires dysbindin; genetic evidence indicates dysbindin levels control the pool of low-release-probability vesicles recruited during homeostatic plasticity at the Drosophila NMJ.\",\n      \"method\": \"Drosophila NMJ electrophysiology, pharmacological proteasome inhibition, EGTA sensitivity assays, genetic epistasis with dysbindin mutants\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — electrophysiology plus pharmacology plus genetic epistasis in Drosophila, single lab\",\n      \"pmids\": [\"29348419\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Genetic variants reducing dysbindin-1 expression alter cognitive response to antipsychotics through an imbalance between short and long isoforms of dopamine D2 receptors, leading to enhanced presynaptic D2 function within the prefrontal cortex; this was demonstrated in postmortem human brains and genetically modified mice.\",\n      \"method\": \"Postmortem human brain analysis, genetically modified mice, D2 receptor isoform quantification, behavioral pharmacology\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — convergent human postmortem and mouse genetic data with molecular mechanism, single lab\",\n      \"pmids\": [\"29891954\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"siRNA knockdown of dysbindin in SH-SY5Y cells causes aberrant actin cytoskeleton organization; growth cones of hippocampal neurons from sandy mice show similar morphological abnormalities; dysbindin expression level correlates with JNK phosphorylation, suggesting dysbindin regulates JNK signaling and actin cytoskeleton organization.\",\n      \"method\": \"siRNA knockdown, phalloidin/immunofluorescence for actin morphology, Western blotting for pJNK in cell lines and primary neurons from sdy mice\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — correlation between dysbindin levels and pJNK without direct mechanistic intervention; single lab, single method per readout\",\n      \"pmids\": [\"19094965\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"Dysbindin-1 (DTNBP1) is a coiled-coil protein that assembles as a core subunit of the octameric BLOC-1 complex, which together with AP-3 mediates endosomal sorting of membrane cargoes (including D2 dopamine receptors and delta-opioid receptors) toward lysosomes and traffics proteins from neuronal cell bodies to nerve terminals; presynaptically, dysbindin regulates vesicle biogenesis, the size of the readily releasable pool, and exocytosis kinetics, thereby controlling glutamate and BDNF release; postsynaptically, it limits NR2A surface expression and modulates LTP; it also undergoes nucleocytoplasmic shuttling via a CRM1-dependent NES to regulate synapsin I expression, interacts with snapin, Munc18-1, WAVE2/Abi-1, RhoA, and DISC1 for diverse synaptic and cytoskeletal functions, and is ubiquitinated and degraded by the E3 ligase TRIM32 (antagonized by TRIM24).\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"Dysbindin-1 (DTNBP1) is a coiled-coil protein that functions as a core, stably assembled subunit of the octameric BLOC-1 complex, coordinating endosomal cargo sorting and presynaptic vesicle biology in neurons [#5, #24]. Originally identified as a direct binding partner of alpha- and beta-dystrobrevin in muscle and brain [#0], its dystrobrevin-binding coiled-coil region is in fact occupied within assembled BLOC-1 by pallidin, snapin, and muted, so the physiological pool is BLOC-1-bound rather than dystrobrevin-bound [#5]. Acting with the AP-3 complex through the AP-3 mu subunit, BLOC-1/dysbindin traffics cargo such as PI4KIIalpha from neuronal cell bodies to nerve terminals [#15, #24], and directs internalized D2 dopamine and delta-opioid receptors toward lysosomal degradation via interactions with GASP-1 and HRS, so that dysbindin loss elevates surface D2 receptor and augments downstream signaling [#6, #18]. Presynaptically, dysbindin sets dense-core and synaptic vesicle size, the readily releasable pool, release probability, and exo/endocytosis kinetics, thereby controlling glutamate and BDNF release [#7, #30, #33]; in Drosophila it is required for retrograde homeostatic modulation of release acting together with NSF and the Arp2/3 actin machinery [#11, #34, #36]. Postsynaptically it limits surface NR2A NMDA receptor expression and constrains hippocampal LTP [#13], and it shapes dendritic spine morphogenesis through a ternary complex with WAVE2 and Abi-1 [#19, #32]. Dysbindin also undergoes CRM1-dependent nucleocytoplasmic shuttling that regulates synapsin I expression [#20] and is degraded by the E3 ubiquitin ligase TRIM32, an activity antagonized by TRIM24 [#10, #37].\",\n  \"teleology\": [\n    {\n      \"year\": 2001,\n      \"claim\": \"Established the molecular identity of dysbindin as a coiled-coil protein with a defined binding partner, anchoring it to the dystrophin/dystrobrevin protein complex in muscle and to synaptic terminals in brain.\",\n      \"evidence\": \"Yeast two-hybrid, reciprocal co-IP, and immunolocalization in muscle and brain\",\n      \"pmids\": [\"11316798\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not establish whether dystrobrevin binding occurs in the physiological assembled state\", \"No functional role defined\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Resolved the apparent dystrobrevin association by showing dysbindin is a stable BLOC-1 subunit whose coiled-coil region is occupied by pallidin, snapin, and muted, reframing its physiological context as an endosomal sorting complex.\",\n      \"evidence\": \"Yeast two-hybrid, recombinant binding assays, and endogenous co-IP from brain and muscle (plus snapin interaction and ultrastructural localization to synaptic vesicles)\",\n      \"pmids\": [\"16448387\", \"16980328\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"BLOC-1 cargo repertoire not yet defined\", \"Functional consequence of snapin binding not yet established\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"First functional role in neurons: bidirectional manipulation showed dysbindin promotes presynaptic protein expression and glutamate release and supports neuronal survival via PI3K-Akt signaling.\",\n      \"evidence\": \"Overexpression/siRNA in primary cortical neurons with glutamate ELISA, pAkt Western, and LY294002 epistasis\",\n      \"pmids\": [\"15345706\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mechanism linking dysbindin to Akt activation unresolved\", \"Single lab, overexpression-based\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Genetic-null analysis defined dysbindin as a regulator of vesicle biogenesis and exocytosis, controlling dense-core vesicle size, release probability, and the readily releasable pool.\",\n      \"evidence\": \"Amperometry, patch clamp, and EM in sandy (sdy) dysbindin-null mice\",\n      \"pmids\": [\"18504299\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular link from BLOC-1 to vesicle biophysics not mapped\", \"Did not distinguish dense-core from clear-vesicle pathways mechanistically\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Connected dysbindin/BLOC-1 to GPCR trafficking and dopaminergic signaling, showing it limits surface D2 receptor levels and shapes interneuron and pyramidal excitability and working memory.\",\n      \"evidence\": \"siRNA and knockout-mouse imaging, fractionation, receptor trafficking assays, and electrophysiology (D2 surface levels, pCREB readouts)\",\n      \"pmids\": [\"17989303\", \"19887632\", \"19641486\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether D2 effect is via altered recycling vs degradation initially ambiguous\", \"Selectivity for D2 over D1 mechanism not fully explained\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Identified the postsynaptic NMDA receptor arm and presynaptic interactome, showing dysbindin selectively restrains surface NR2A to constrain LTP and binds Munc18-1 and AP-3 mu at terminals.\",\n      \"evidence\": \"Imaging/biotinylation and LTP recordings in null mice; proteomics, co-IP, and in vitro binding for Munc18-1 and AP-3\",\n      \"pmids\": [\"19955431\", \"19573021\", \"19428785\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism of NR2A-selective regulation undefined\", \"How vesicle partners and trafficking integrate not resolved\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Defined a degradation control point: TRIM32 ubiquitinates dysbindin to drive its turnover, with LGMD2H/STM disease alleles impairing this ligase activity.\",\n      \"evidence\": \"Yeast two-hybrid, in vitro/cell ubiquitination assays, siRNA, and disease-allele mutagenesis (D487N, R394H)\",\n      \"pmids\": [\"19349376\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Physiological signals controlling TRIM32-dysbindin turnover unknown\", \"In vivo consequence of altered turnover not tested\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Mechanistically unified dysbindin's trafficking role by showing BLOC-1/AP-3 transports cargo (PI4KIIalpha) from neuronal cell bodies to neurites, defining the somatodendritic-to-terminal sorting pathway.\",\n      \"evidence\": \"Co-purification, AP-3 and BLOC-1 knockout mice, sorting-motif mutagenesis, and imaging in neurons/PC12 cells\",\n      \"pmids\": [\"21998198\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Full cargo set transported by this route not enumerated\", \"Link between cargo mis-sorting and synaptic phenotypes incompletely traced\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Expanded dysbindin beyond trafficking into cytoskeletal, nuclear, and transcriptional roles, including WAVE2/Abi-1-dependent spine morphogenesis, CRM1-dependent shuttling regulating synapsin I, and necdin/p53-dependent neurite outgrowth.\",\n      \"evidence\": \"Co-IP/Y2H, RNAi morphology, leptomycin B/NES mutagenesis, and p53 reporter/rescue assays in neurons and sdy mice\",\n      \"pmids\": [\"20531346\", \"20921223\", \"21502952\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Relationship between nuclear shuttling and BLOC-1 function unclear\", \"Single-lab findings for several non-canonical roles\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Linked dysbindin to disease-relevant protein interactions and Drosophila cell-type dissection, including direct DISC1 binding/co-aggregation in patient brain and distinct neuronal vs glial roles controlling glutamatergic transmission and dopamine metabolism.\",\n      \"evidence\": \"Cell-free recombinant binding/domain mapping and postmortem brain co-IP; cell-type-specific RNAi with electrophysiology and behavior in Drosophila\",\n      \"pmids\": [\"21531389\", \"22049342\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Functional consequence of DISC1 co-aggregation in vivo not established\", \"Conservation of glial mechanism to mammals untested\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Defined effector machinery for homeostatic plasticity and actin-dependent endosomal function, showing dysbindin/BLOC-1 controls NSF and Arp2/3 levels and copper-stress resistance, with NSF or dysbindin rescuing homeostatic plasticity in Drosophila.\",\n      \"evidence\": \"Proteome-wide screens, co-IP, actin dynamics assays, and Drosophila genetic rescue/interaction electrophysiology\",\n      \"pmids\": [\"27927957\", \"25972187\", \"26199316\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct vs indirect regulation of NSF/Arp2/3 abundance unresolved\", \"Mammalian relevance of copper phenotype incompletely defined\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Identified a transsynaptic signaling output: dysbindin controls BDNF exocytosis from excitatory neurons, which in turn sets the number of inhibitory synapses, rescuable by exogenous BDNF.\",\n      \"evidence\": \"TIRF live-cell BDNF imaging, whole-cell recordings, IHC, and BDNF rescue in cortical neurons and slices\",\n      \"pmids\": [\"26386481\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism coupling dysbindin to BDNF vesicle exocytosis specifically not detailed\", \"In vivo circuit-level validation limited\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Established antagonistic control of dysbindin stability beyond muscle, with TRIM24 shielding dysbindin from TRIM32-mediated degradation to tune RhoA-SRF-driven cardiomyocyte hypertrophy.\",\n      \"evidence\": \"Yeast two-hybrid, co-IP, TRIM24/TRIM32 manipulation Westerns, and SRF reporter/hypertrophy assays in cardiomyocytes\",\n      \"pmids\": [\"28465353\", \"24385487\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether TRIM24/TRIM32 balance regulates neuronal dysbindin untested\", \"Upstream regulation of the TRIM switch unknown\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Refined the dopaminergic mechanism and clinical relevance, showing dysbindin expression controls vesicle pools recruited during homeostatic plasticity and the D2 short/long isoform balance shaping prefrontal D2 function and antipsychotic response.\",\n      \"evidence\": \"Drosophila NMJ electrophysiology with proteasome inhibition/EGTA assays; postmortem human brain and genetically modified mouse D2 isoform analysis\",\n      \"pmids\": [\"29348419\", \"29891954\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Causal chain from dysbindin level to D2 isoform ratio not fully mapped\", \"Single-lab human-mouse convergence\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How dysbindin's multiple roles—BLOC-1 endosomal sorting, presynaptic vesicle pool control, postsynaptic receptor surface regulation, nuclear shuttling, and proteostatic turnover—are coordinated within a single neuron and selectively engaged across cell types remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No integrated model linking BLOC-1 trafficking to the non-canonical nuclear/transcriptional roles\", \"Structural basis of cargo selection by dysbindin/BLOC-1 undefined\", \"In vivo hierarchy of pre- vs post-synaptic dysbindin functions unestablished\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0060090\", \"supporting_discovery_ids\": [5, 15, 24]},\n      {\"term_id\": \"GO:0008092\", \"supporting_discovery_ids\": [19, 34, 32]},\n      {\"term_id\": \"GO:0005198\", \"supporting_discovery_ids\": [5]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005768\", \"supporting_discovery_ids\": [18, 24, 34]},\n      {\"term_id\": \"GO:0031410\", \"supporting_discovery_ids\": [4, 7, 25]},\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [17, 20]},\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [20]},\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [6, 12, 18]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-5653656\", \"supporting_discovery_ids\": [18, 24, 6]},\n      {\"term_id\": \"R-HSA-112316\", \"supporting_discovery_ids\": [7, 13, 30, 33]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [6, 12, 28]},\n      {\"term_id\": \"R-HSA-392499\", \"supporting_discovery_ids\": [10, 37]},\n      {\"term_id\": \"R-HSA-9609507\", \"supporting_discovery_ids\": [24]}\n    ],\n    \"complexes\": [\n      \"BLOC-1\"\n    ],\n    \"partners\": [\n      \"SNAPIN\",\n      \"PLDN\",\n      \"MUTED\",\n      \"AP3M1\",\n      \"STXBP1\",\n      \"WASF2\",\n      \"ABI1\",\n      \"TRIM32\"\n    ],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":6,"faith_total":6,"faith_pct":100.0}}